WO1995018626A1 - A tonic drug made from basidiomycetes, algae, chinese herbal medicine and the method thereof - Google Patents

A tonic drug made from basidiomycetes, algae, chinese herbal medicine and the method thereof Download PDF

Info

Publication number
WO1995018626A1
WO1995018626A1 PCT/CN1994/000070 CN9400070W WO9518626A1 WO 1995018626 A1 WO1995018626 A1 WO 1995018626A1 CN 9400070 W CN9400070 W CN 9400070W WO 9518626 A1 WO9518626 A1 WO 9518626A1
Authority
WO
WIPO (PCT)
Prior art keywords
bran
puree
following weight
mushroom
kelp
Prior art date
Application number
PCT/CN1994/000070
Other languages
French (fr)
Chinese (zh)
Inventor
Lushan Lin
Original Assignee
Lushan Lin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lushan Lin filed Critical Lushan Lin
Priority to AU75300/94A priority Critical patent/AU7530094A/en
Publication of WO1995018626A1 publication Critical patent/WO1995018626A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/47Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02Algae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/465Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals

Definitions

  • the invention relates to a biological fermentation product and a preparation method thereof, in particular to a health care medicine obtained by using a fermentation fermentation technology and a preparation method thereof.
  • the purpose of the present invention is to overcome the shortcomings of the prior art, and to provide a biological fermentation product with multiple health-enhancing and therapeutic effects, which is mainly composed of fungi, seaweed and Chinese herbal medicine ⁇
  • Another object of the present invention is to provide a method for preparing the above-mentioned biological fermentation product, so as to avoid the disadvantageous color noise generated by using traditional Chinese medicine processing methods, such as high temperature heating.
  • the present invention relates to a biological fermentation product, which comprises the fruit bodies and seaweeds of Basidiomycetes 32-48 * based on the total weight of the main family, and 52-68 * Chinese herbal medicines based on the original protoplast, bacterial oxalase, and Fermentation products with enzyme-promoting agent, carbon source, and nutritional supplements as supplementary raw materials, of which:
  • the weight ratio of the basidiomycete to the seaweed is 2: 0. 5-1. 5;
  • the basidiomycete is selected from one or more kinds of lentinus, edulis, Poria, Hog, Poria, Ganoderma lucidum, Hericium erinaceus, mushroom, Tremella;
  • the seaweed is selected from one or two of kelp, laver, seaweed, and hairweed;
  • the bacterial oxalase is selected from one or more of ⁇ -amylase, cellulase, pectinase, and fungal protease, and the added rhenium is 0.01-0.0 of the total weight of the raw materials;
  • the enzyme-promoting agent is selected from yeast mash or corn slurry or a mixture thereof;
  • the nitrogen source and carbon source are selected from the group consisting of peptone, bran, fine bran, sweet potato flour, corn flour, bran, rice bran, One or more of mashed potato powder, tulipa powder, bean cake powder, peanut cake powder, rapeseed cake powder, black sesame powder, brown sugar, and white sugar;
  • the nutritional additives are inorganic salts and substances combined with phosphorus, calcium, potassium, magnesium, selenium, and zinc; the weight ratio of the main raw material to the fermentation promoter, nitrogen source, carbon source, and nutritional additive is 100: 0.02 -0.1: 0.18-0.22: 4.6-5.4: 0.14-0.16.
  • the method for preparing a biological fermentation product of the present invention includes the following steps:
  • the main drug source of the drug is taken, which includes 32-48 weight percent of fungi and seaweed, and 52-68 weight percent of Chinese herbal medicine; bacterial oxalase; the enzyme production promoter, nitrogen source, carbon source and Nutritional additives as pharmaceutical auxiliary materials;
  • the choice of various kinds of raw materials and their amounts have the same definition as above.
  • the various bacterial oxalase enzymes are prepared as follows:
  • the 0! -Amylase is derived from corn starch 2, corn slurry 26 *, disodium hydrogen phosphate 37 *, calcium fluoride
  • the fungal protease is derived from corn starch 303 ⁇ 4, corn slurry 5 *, soy flour 53 ⁇ 4, casein gelatin dried distiller's grains 53 ⁇ 4, dipotassium phosphate 2.4%, sodium nitrate 1 ammonium gasification: ⁇ , iron sulphate 0.01 bran 5 *, Fine bran 5 *, culture product of Ganoderma spore pink koji 1 ⁇ 2, wherein the percentage is weight percentage;
  • the cellulase is derived from edible fungus green waste fungus 653 ⁇ 4 ⁇ , bran 10%, bran 10 lucic acid Solid fermentation product of ammonium 2.5%, water 250%, yeast expensive 1 Tween 80.0.05%, crude brown sugar 1 red yeast rice 1 *, the percentage of which is weight percentage;
  • bran 0.5 ammonium sulphate 0.2 potassium dihydrogen phosphate 0.1, calcium carbonate 0.1%, glucomannose 1 * in a triangle flask, 30 e C, 104 rpm, culture 32-35 hours The first-stage fermentation product of the seed was obtained; the waste fungus material 6 bran 0.53 ⁇ 4, glucosamine ammonium gluconate 0.2% potassium dihydrogen phosphate 0.1% were at 30 e C, 104 Turn / min and culture for 60 hours to obtain a secondary seed culture; seed primary and secondary cultures, peptone 0.075%, Tween 80 0.2%, ammonium sulphate 1.4g / I potassium dihydrogen phosphate S.
  • the pectinase is derived from 4% of pectin, 0.4% of peptone, 0.05% of sodium sulphate, 0.01% of iron sulphate, 0.05% of magnesium sulphate, 0.05% of potassium vaporization, 55% of potassium dihydrogen phosphate bran, 5% fine bran, sucrose 2%, ammonium nitrate 0.2%, sodium nitrate 0.2 and connected to the spore suspension wave of ganoderma spores containing 2 10 3 spores, 30-C, culture product obtained by culturing in a conical flask for 7 days, where the percentage is weight percentage .
  • the above preparation method of the present invention enables some ingredients in Chinese herbal medicines to be changed during the preparation process, that is, the molecular structure of the drug components is changed, so that it can most effectively exert the persuasion of the original subjects, so that the prepared medicine has more It is suggested that health care can be effective, and some difficult diseases of Meike are treated, and the preparation steps are simple and easy.
  • the biological fermentation product of the present invention is preferably the following combined fermentation product of the original family, and each component used in the preparation method thereof has the following weight percentages based on the total weight of the raw materials:
  • the basidiomycetes and seaweeds have the following weight percentages: Lentinus edodes 7-83 ⁇ 4, Flammulina velutipes 18-193 ⁇ 4, Poria 1-2%, Ganoderma 2-3 kelp 14-163 ⁇ 4;
  • the Chinese herbal medicine has the following weight percentage components: Boziren 7-8 *, Shezizi 3-4 Cuscuta 3-4 Raspberry 3-4%, Dendrobium 2-3%, Morinda officinalis 1-2, Continued off 4-5 Black medicine 0.5-1%, Calamus 1-1.5%, Alisma 0.5-1%, Chinese yam 1-2 ginseng 1-2%, 'Rehmannia glutinosa 2- 3 mulberry parasitic 0.5-1%, Dogwood 1-1 Schisandra 3-5%, stalactites 1-23 ⁇ 4, Cistanche 2-3% and ox vine 0.7-13 ⁇ 4 ⁇ ;
  • the auxiliary raw materials are components with the following weight percentages: peptone 0.01-0.02%, brown sugar 0.2-0.3%, stone powder: 1, KCI 0.4-0.5%, MgSO 4 0. -0.5%, KH 2 PO 4 0.4-0.5%,
  • the bacterial oxalase ⁇ fiber's enzyme produced by the above method is the bacterial oxalase ⁇ fiber's enzyme produced by the above method.
  • the mixture of basidiomycete puree and / or seaweed puree used for inoculation is: Enoki mushroom puree, mushroom puree, Ganoderma lucidum and kelp puree with a weight ratio of 2: 1.
  • the basidiomycetes and seaweeds have the following weight percentages: Shiitake mushrooms 7-8%, Enoki mushroom 4-6 soil Poria 1-23 ⁇ 4, Ganoderma 2-33 ⁇ 4, kelp 7-8%;
  • the Chinese herbal medicine has the following weight percentage components: Bo Zi Ren 4-5 *, She Chuang Zi 4-4.5 ⁇ Silk seeds 4-4.5%, raspberries 4-4.5 ⁇ fe, Dendrobium 1-1.53 ⁇ 4 ;, Morinda officinalis 1.-1.5%, Eucommia ulmoides 1-1.5 Asparagus 1-1.5%, Zhiyuan (heart removal) 1 : 1.5 1 ⁇ 2: Zhiren 0.2-0.5 continuity 0.5-0.73 ⁇ 4 ;, Wuya 0.5-0.7 alfalfa 0.7-1 Alisma 0.7-1S ;, yam 0.8- ⁇ , ginseng 0.8-1 rehmannia 0.5-0.8 dogwood S.6- 1%, Five Gardenias 2-3 Stalactites (refined) 1-1.23 ⁇ 4 ;, Cistanche 2-3
  • the auxiliary progenitors are components having the following weight percentages: bran 7-8%, fine bran 7-8 sweet potato powder 4-4.2%, yeast 1-1.23 ⁇ 4f, sucrose, calcium carbonate 1-1.2
  • the bacterial oxalase is a cellulase made by the above method.
  • the mixture of basidiomycete puree and / or seaweed puree used for inoculation is: Enoki mushroom puree, mushroom puree, Ganoderma lucidum and kelp puree with a weight ratio of 2: 1.
  • the basidiomycetes and seaweeds have the following weight percentages: Poria cocos, Potentilla 7-83 ⁇ 4, kelp 7-83 ⁇ 4;
  • the Chinese herbal medicine has the following weight percentage components: Polygonum multiflorum (manufactured) 5-6%, Achyranthes bidentata 3-43 ⁇ 4, Cuscuta 3-4, Ligustrum 3-4%, Eucommia ulmoides 4-5, County sign grass 5- 6%, mulberry leaves 2-3%, silver flowers 3-4%, black mulberries 3-4%, medlar 0.3-0., Chrysanthemums 5 -6% Dihuang 3 _43 ⁇ 4, mangosteen 3-43 ⁇ 4, tannin 3 _ 4 %, Alisma 0.3-0.43 ⁇ 4, yam 3-4%;
  • the auxiliary raw tincture is a component having the following weight percentages: bran 7-, fine bran 7-8%, yeast 1-1.2%, sucrose 1-1.2%, calcium carbonate 1-1.2 *;
  • the bacterial oxalase is 0.02 * cellulase and 0.01% pectinase;
  • the mixture of basidiomycete puree and / or seaweed puree used for inoculation is: shiitake mushroom puree, mushroom puree, kelp puree.
  • the basidiomycetes and seaweeds have the following weight percentages: Lentinus 3-, Mushroom 3-4%, Hericium 3- «, Kelp 5-6%;
  • the Chinese herbal medicine has the following weight percentage components: Huangyaozi 10-20 *, Chuandi 4-5 *, Shayuanzi 4-5, Oyster 3-43 ⁇ 4, Curcuma 3-4%, Coix Seed 3-, Chuanxiongzi 4 -5 green peel 3 -4%, ⁇ 1.2-1.5%, spot ⁇ 1.2-1.5 *, talc 3-43 ⁇ 4 ⁇ , unicorn 3-4 amomum 2-33 ⁇ 4 !, chicken gizzard inside 2-3%, codonopsis 2 -3%, astragalus 3-63 ⁇ 4, cooked rehmannia 3-6 *, 'er ug 3-61 ⁇ 2, betel nut slices 3-6%, Sichuan army 1-2 yuan Ming powder 1-2 dried toad 0.5-1 *, acute 0.6 -1, 2 Zhuru 2 ⁇ 3 ⁇ 3 ⁇ 4 and ochre 4-5 *;
  • the auxiliary raw materials are components having the following weight percentages: bran 4-5 fine bran 4-5%, yeast 1.2-1.5%, brown sugar 3-, soybean powder 3-, calcium carbonate 1-1.2%;
  • the bacterial oxalase is 0.023 ⁇ 4 of the above-mentioned cellulase and 0.01% of the above-mentioned pectinase;
  • the mixture of basidiomycete puree and / or seaweed puree used for inoculation is: shiitake mushroom puree, kelp puree, and ganoderma puree.
  • the basidiomycetes and seaweeds have the following weight percentages: 10-15% Tremella, 1.5-4.5 Shiitake 5-;
  • the Chinese herbal medicine has the following weight percentage components: Xuanshen 3-, Ophiopogon 3-, Raw Rehmannia 3-4%, Chiba 1-2 Danshen 1-2S ;, Astragalus 3-4%, Yam 3- , Coix 1-2 *, Safflower 1_2 *, Bupleurum 0.5-5-0. 6 * and sea cucumber 7-8%;
  • the auxiliary raw materials are components having the following weight percentages: bran fine bran 6-8 sweet potato powder 6-8%, yeast 1.2-23 ⁇ 4, sucrose 1.2-2%, calcium carbonate 1-1.2
  • the bacterial oxalase is 0.02 * of the above-mentioned cellulase and 0.01% of the above-mentioned pectinase;
  • the mixture of basidiomycete puree and / or seaweed puree used for inoculation is: shiitake mushroom puree, kelp puree, and ganoderma puree.
  • the basidiomycetes and seaweeds have the following weight percentages: Lentinus 2-3, Poria cocos 1-23 ⁇ 4, Poria cocos 4-5%, Kelp 4-5;..
  • the Chinese herbal medicine has the following weight percentage components: Astragalus 1-2, Codonopsis 1-2 *, Fangfang 1-2, Atractylodes 1-2, Shouwu 2-4 *, Zexie 4-8, Hawthorn 2-4, Yinchen 2-4%, buffalo horns 2-4 *, epimedium 2-4 * and rhubarb
  • the auxiliary raw materials are components having the following weight percentages: bran 10-12%, fine bran 5-63 ⁇ 4, sweet potato flour 5-6%, baker's yeast 1-1.2 brown sugar 1-1.2 *, calcium carbonate 1-1.2 *;
  • the bacterial oxalase is 0.0023 ⁇ 4; the above-mentioned cellulase O. 01 * ’s fungal protease; the mixture of basidiomycete puree and / or seaweed puree used for inoculation is: shiitake puree, Mushroom puree, seaweed puree.
  • the basidiomycetes and seaweeds have the following weight percentages: shiitake mushrooms 15-20%, kelp
  • the Chinese herbal medicine has the following weight percentage components: Polygonum multiflorum 18-223 ⁇ 4 ;, Ligustrum lucidum 9-10 *, Huai yam 9-10%, Mulberry and Hangbaiju 3 ⁇ ;
  • the auxiliary raw material is a component having the following weight percentages: bran 10-12 ⁇ fine bran 5-63 ⁇ 4, yeast 1-1.2 *, brown sugar 1.5-2 ⁇ 5 *, calcium carbonate 1-1.2 *;
  • the bacterial oxalase is the above-mentioned cellulase of 0.02 * and the above-mentioned amylase of 0.03 ⁇ ;
  • the mixture of basidiomycete puree and / or seaweed puree used for inoculation is: Zhizhi puree, ⁇ Needle mushroom puree, kelp puree.
  • the bacterial oxalase used in the present invention is a permanganase, but the pure hydrolyzed enzymes sold in the present invention are not effective because the enzymes are mainly produced by fungi and it is difficult to effectively treat Chinese herbal medicines. break down.
  • the bacterial oxalase in the present invention is produced by co-fermentation of fungi and group fungi.
  • the above-mentioned cellulase is mainly used, or one of the above-mentioned cellulose is selected from the above-mentioned amylase, pectinase, and protease. Enzymes are used together.
  • the basidiomycetes, algae, and Chinese herbal medicines of the present invention are all dry products with impurities removed, and the weight of each raw material is weighed according to the formula. ⁇ , ' ⁇ ',
  • the above fungi and algae are pulverized and ground into powder, respectively, and the Chinese herbal medicine is pulverized into a 16-20 mesh fineness powder.
  • the enzyme promoter, ammonia source, carbon source, and nutritional additive of each auxiliary original product are further mixed, and then mixed and stirred evenly.
  • the present invention is produced by a liquid deep aeration fermentation method.
  • the above-mentioned fully-mixed raw soup is first placed in a bioreactor, the fermentation temperature is 30 "C-5 5 V, and the p H value is adjusted to 4.0-6 with lactic acid. 5, fermentation time 5-8 days, stirring 1 "2 times a day. 24 hours from the start of fermentation, a mixture of 1-2% of the basidiomycete puree and / or seaweed puree is added at intervals of 24 hours.
  • the fermented mixture was placed in an ultracentrifuge, and the temperature of the rotor was controlled at zero. -5 ⁇ (: between, centrifugation time 10 minutes / times, take the clear wave, centrifuge the slag plus lactic acid to extract for 24 hours and ultracentrifuge again to get the clear wave, combine the original supernatant after the second supernatant centrifugation Dregs can be used as feed additives.
  • the two obtained supernatants were adsorbed with a pore size 18 ⁇ -2 A activated carbon, and unsaturated fatty acids were removed and decolorized.
  • the decolorized supernatant water is concentrated by a dehydrator to a gelatinous body with a combined water content of 30-35%.
  • the finished powder product is vacuum packed into bottles at 10 mg / bottle.
  • the fermentation time is 72 hours, the temperature is 37 ⁇ l e C, and the pH value is 6.0-7.0.
  • the culture product contains 30% of the dried amylase.
  • basidiomycetes and seaweed 440 g of Lentinus edodes, 110 g of Flammulina velutipes, 110 g of Poria cocos, 20 g of Ganoderma lucidum, 2 2 O.g of kelp;
  • Chinese herbal medicines Bo Ziren 230 g, Snake Bed 110 g, Cuscuta 110 g., Raspberry 110 g, Dendrobium 75 g, Morinda officinalis 45 g, Eucommia 90 g, Asparagus 9 0 g, Polygala spp.
  • the fermented mixture was centrifuged in an ultra-centrifuge centrifuge at 2 'C for 10 minutes, and the clear water was taken. The centrifuged residue was leached with lactic acid for 24 hours. The centrifuge was centrifuged for 10 minutes and combined twice. The clear solution is adsorbed with activated carbon with a pore size of 18 A to remove the unsaturated medium fat. After the fat is decolorized, it is concentrated by a dehydrator to a colloid with a water content of 35%, and then placed in a temperature-controlled drying box at about 60 C. Dry for 4 hours to make 2 kg of powdered finished product with a total volume of 6%.
  • basidiomycetes and seaweed 70 g of Lentinus edodes, 60 g of Flammulina velutipes, 10 g of Poria cocos, 30 g of Ganoderma lucidum, and 70 g of kelp;
  • bran 70 g of bran, 80 g of fine bran, 40 g of sweet potato powder, 12 g of yeast, sucrose
  • the mixture used to inoculate the basidiomycete puree and / or seaweed puree is: 0.16 g puree of mushrooms, 0.08 g of puree of mushrooms, ganoderma and kelp (1: 1) puree 0. 0 9 g.
  • Example 1 The method of Example 1 was repeated to produce 300 g of a powder finished product with a water content of 6%.
  • basidiomycetes and seaweeds 70 g of Poria cocos, 80 g of Ganoderma lucidum and 70 g of kelp;
  • Chinese herbal medicine Polygonum multiflorum (manufactured) 50 g, Austrodia chinensis 40 g, Cuscuta chinensis 40 g, Ligustrum lucidum 40 g, Eucommia ulmoides 40 g, Agaricus syringa 60 g, Mulberry leaf 20 g, 40 g of silver flower, 40 g of black mulberry, 4 g of wolfberry, 60 g of chrysanthemum, 40 g of rehmannia glutinosa, 30 g of yam meat, 40 g of tannin, 4 g of diarrhea, and 40 g of yam;
  • the mixture of basidiomycete puree and / or seaweed puree used for inoculation is: 0.16 g of mushroom puree, 0-16 g of mushroom puree, and 0 ⁇ 0 9 g of kelp puree.
  • Example 1 The method of Example 1 was repeated to prepare a powder finished product with a water content of 6 9 & 9 4 0 g.
  • This product can calm blood and nourish yin, dissipate blood stasis and clear collaterals, and lower blood lipids.
  • bran 45 g of bran, 45 g of fine bran, 15 g of yeast, 35 g of brown sugar, 3'5 g of soy flour, 10 g of calcium carbonate ;
  • the mixture of basidiomycete puree and / or seaweed puree used for inoculation is: 0.2 g of mushroom puree, kelp puree 0.1 g, ganoderma puree 0,, 1 g ?.
  • Example 1 The method of Example 1 was repeated to produce a finished product of 6% of the total volume of 11.8 g.
  • the mixture of basidiomycete puree and / or seaweed puree used for inoculation is: lenticular puree 0.16 g, kelp puree 0. 8 g, and ganoderma puree 0. 9 g.
  • Example 1 The method of Example 1 was repeated to produce a finished product 715 g with a water content of 6%.
  • Alisma 40 g Hawthorn 40 g, Yin Chen 40 g, Buffalo Horn 30 g, Epimedium 30 g and Rhubarb 6 g;
  • auxiliary raw mash 100 g of bran, 60 g of fine bran, 60 g of sweet potato flour, 12 g of baker's yeast, 12 g of brown sugar, and 12 g of calcium carbonate;
  • the mixture of basidiomycete puree and / or seaweed puree used for inoculation is: 0.15 g of mushroom puree, 0.08 g of mushroom puree, and 0.99 g of ganoderma puree.
  • Example 1 The method of Example 1 was repeated to obtain a finished product of 6 8 5 g with a hydration content of 6 %.
  • Chinese herbal medicine Polygonum multiflorum 220 g, Ligustrum lucidum 100 g, Huai yam 100 g, Mulberry 50 g and Hangbai chrysanthemum 40 g;
  • auxiliary materials 120 g of bran, 60 g of fine bran, 12 g of yeast, 20 g of brown sugar, 12 g of calcium carbonate;
  • Bacterial oxidase was used as reference ⁇ vitamin E enzyme 2 ⁇ 2 g made in Reference Example 3 -B and ⁇ amylase 0.1 g made in Reference Example 1;
  • This product has the functions of nourishing blood, nourishing liver, nourishing sage, and promoting hair growth. It is used for baldness, alopecia areata, alopecia areata, and young white hair.
  • the invention has the following characteristics, and thus can have a wide range of applications:
  • the persuasive health care medicine prepared by the method of the present invention is combined with bacterial protein, seaweed single-cell soluble protein, active ingredients of Chinese herbal medicines, and trace nutrients.
  • Nutrient elements It is composed of small molecule proteins with strong cell activity. And peptide substances, can penetrate the brain barrier and cell membranes, reach diseased areas, and kill disease factors and viruses. Clinically proven, this drug has a significant effect on the treatment of diseases such as aging and aging, and can delay the aging effect.
  • the persuasion, health-preserving medicine of the present invention has the obvious persuasion effect that the curative effect is good and the effect is fast compared with the similar formula and the medicine made by other processing methods.
  • the total amount (weight percentage) of various components measured in the health medicine prepared by the method of the present invention is: protein 10.0463 ⁇ 4 fat 2.843 *
  • Iron 150 Vitamin (mg / 100g)
  • Amino acid germanium Oppm / ipog,. ⁇ .
  • Example 1 20 mice were used for experiments; the females were half prepared, and the highest concentration (28%) of the biological fermentation product of the present invention was 0.4ml / 10gBW. Once every 4 hours, 3 times in a row. Toxicity and death were observed at the end of 7 days.
  • LD 5 was calculated by intragastric administration of the biologically fermented mice of the present invention. More than 33.6g / kg, equivalent to 917 times the recommended clinical dosage. ''
  • Example 5 For all kinds of diseases caused by visceral deficiency and yin-yang tone; It has 62 cases of sexually transmitted diseases and senile diseases. It is clinically applied in Example 2.
  • the products are diagnosed according to the "Specifications for the Diagnosis and Treatment of Traditional Chinese Medical Diseases". The standard indicates that: the total effective rate for heart-yang deficiency (total 21 cases) is 95%; the total effective rate for heart-spleen deficiency (total 20 cases) is 90%; 1 case) with a total effective rate of 90; the total effective rate with respect to life-gate fire decay (a total of 10 cases) was 92%.
  • the preparation process of the present invention is simple and easy, the equipment is simple, the original tin is easy to obtain, the cost is low, and it is convenient for popularization and application.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a tonic drug made from basidiomycetes, algae, chinese herbal medicine and hydrolases by method of biological fermentation and the method thereof. The description of the drug comprises 32-48 % by weight of basidiomycetes and algae and 52-68 % by weight of chinese herbal medicine. Said drug contains large amount of small molecular active proteins and polypeptides, enriched in nutritions and is effective in health protection, senile-resistance and treating some difficult and complicated cases of illness.

Description

以苗类、 海 类.中革葯为主原料的多劝能保健葯物及其制法 技术领蜮  Multi-encouraging health-care medicines based on seed, sea and Chinese leather medicines and their preparation methods
本发明涉及一种生物发酵物及其制备方法, 特别是涉及利用徵生物发酵酶解 技术得到的保健葯物及其制备方法。 背景技术  The invention relates to a biological fermentation product and a preparation method thereof, in particular to a health care medicine obtained by using a fermentation fermentation technology and a preparation method thereof. Background technique
在传统中医学中有应用担子菌、 半知菌等某些菌类、 海藻与中草药配伍治疗 某些疾病的成劝实例。 '然 '而这是属于饮片疗效。 是配方中药材通过净制、 切制后 应用于临床。 伹是中药材在实际制备过程中, 往往由于加热温度难于掌握, 或造 成药毒性增加, 例如束砂在高温度下会析出游'离汞, 使药物毒性增大; 或是由于 加热不正当造成有些药物药效成分破坏, 彩响疗效, 例如合雷丸、 花粉、 蜂王浆 等中成药往往出现原科蛋白质、 氨基酸合量减少。 合挥发性类药物在炮制过程中 挥发油合量减少更加明显。 此外, 炮制过程中药物在水中溶解度掌握不当会影响 徹。 总之, 中医学中原料配伍炮制无法准确地反映出原料的总体综合效用。  In traditional Chinese medicine, there are some examples of the application of certain fungi such as basidiomycetes and fungi, seaweeds and Chinese herbal medicine to treat certain diseases. '然' And this is a curative effect. It is a Chinese medicinal material formulated for use in the clinic after being prepared and cut. Rhenium is that in the actual preparation process of Chinese medicinal materials, it is often difficult to grasp the heating temperature or increase the toxicity of the medicine, for example, the sand at the high temperature will precipitate free mercury, which will increase the toxicity of the drug; or due to improper heating Some medicines have their active ingredients destroyed, and they have a colorful effect. For example, proprietary Chinese medicines such as Helei pills, pollen, and royal jelly often show a decrease in the amount of original proteins and amino acids. In the process of processing volatile drugs, the reduction of volatile oil content is more obvious. In addition, improper control of the solubility of the drug in water during processing can affect the completeness. In short, the processing of raw materials in traditional Chinese medicine cannot accurately reflect the overall comprehensive effectiveness of raw materials.
^月 ^ Month
本发明的目的在于克服现有技木的不足, 提供一种具有多劝能保健和治疗作 用的生物发酵物, 其是以菌类、 海藻类、 中草药为主原料 β The purpose of the present invention is to overcome the shortcomings of the prior art, and to provide a biological fermentation product with multiple health-enhancing and therapeutic effects, which is mainly composed of fungi, seaweed and Chinese herbal medicine β
本发明的另一个目的在于提供制备上述生物发酵物的方法, 以避免釆用传统 的中药炮制方法, 如高温加热所产生的不利彩响。  Another object of the present invention is to provide a method for preparing the above-mentioned biological fermentation product, so as to avoid the disadvantageous color noise generated by using traditional Chinese medicine processing methods, such as high temperature heating.
本发明涉及一种生物发酵物, 其中合有按主原科总重量计 32-48*的担子菌的 子实体和海藻类, 以及 52-68*的中草药为主原枓, 菌草酸酶, 以及以产酶促进剂、 m 碳源、 营养添; ίιπ剂为辅助原料的发酵产物, 其中:  The present invention relates to a biological fermentation product, which comprises the fruit bodies and seaweeds of Basidiomycetes 32-48 * based on the total weight of the main family, and 52-68 * Chinese herbal medicines based on the original protoplast, bacterial oxalase, and Fermentation products with enzyme-promoting agent, carbon source, and nutritional supplements as supplementary raw materials, of which:
所述的担子菌与海藻类的重量比为 2: 0. 5-1. 5;  The weight ratio of the basidiomycete to the seaweed is 2: 0. 5-1. 5;
所述的担子菌选自香菇、 佥针兹、 茯苓、 猪苓、 炅芝、 猴头菇、 蘑菇、 银耳 中的一种或数种;  The basidiomycete is selected from one or more kinds of lentinus, edulis, Poria, Hog, Poria, Ganoderma lucidum, Hericium erinaceus, mushroom, Tremella;
所述的海藻类选自海带、 紫菜、 海藻、 发菜中的一种或两种;  The seaweed is selected from one or two of kelp, laver, seaweed, and hairweed;
所述的菌草酸酶选自 α -淀粉酶, 纤维酶, 果胶酶, 真菌蛋白酶中的一种或 多种, 其添加 Ϊ为原料总重量的 0.01-0.0 ;  The bacterial oxalase is selected from one or more of α-amylase, cellulase, pectinase, and fungal protease, and the added rhenium is 0.01-0.0 of the total weight of the raw materials;
所述的产酶促进剂选自酵母赍或玉米浆或其混合物;  The enzyme-promoting agent is selected from yeast mash or corn slurry or a mixture thereof;
所述的氮源和碳源选自蛋白胨、 麸皮、 细糠、 地瓜粉、 玉米粉、 麸皮、 米糠, 马钤薯粉、 土茯苓粉、 豆饼粉、 花生饼粉、 菜籽饼粉、 黑芝麻粉、 红糖、 白糖中 的一种或多种; The nitrogen source and carbon source are selected from the group consisting of peptone, bran, fine bran, sweet potato flour, corn flour, bran, rice bran, One or more of mashed potato powder, tulipa powder, bean cake powder, peanut cake powder, rapeseed cake powder, black sesame powder, brown sugar, and white sugar;
所述的营养添加剂是合有磷、 钙、 钾、 镁、 硒、 锌的无机盐和 ^物质; 上述主原枓与产酵促进剂、 氮源、 碳源、 营养添加剂的重量比为 100: 0.02 -0.1: 0.18-0.22: 4.6-5.4: 0.14-0.16。  The nutritional additives are inorganic salts and substances combined with phosphorus, calcium, potassium, magnesium, selenium, and zinc; the weight ratio of the main raw material to the fermentation promoter, nitrogen source, carbon source, and nutritional additive is 100: 0.02 -0.1: 0.18-0.22: 4.6-5.4: 0.14-0.16.
本发明的生物发酵物的制备方法, 包合如下步骤:  The method for preparing a biological fermentation product of the present invention includes the following steps:
(1) 取药物主原枓, 其中包括重量百分比为 32 -48的菌类和海藻类, 和重量 百分比为 52-68的中草药; 菌草酸酶; 取产酶促进剂、 氮源、 碳源和营养添加剂 作为药物辅助原料; · ·  (1) The main drug source of the drug is taken, which includes 32-48 weight percent of fungi and seaweed, and 52-68 weight percent of Chinese herbal medicine; bacterial oxalase; the enzyme production promoter, nitrogen source, carbon source and Nutritional additives as pharmaceutical auxiliary materials;
(2) 将上述的菌类和海藻类以及上述中草药分别粉碎成粉末状;  (2) pulverizing the above-mentioned fungi and seaweed and the above-mentioned Chinese herbal medicine into powders;
(3) 将上述中草药粉末用 的乳酸水溶液浸泡 24小时, 然后加入上述粉碎 后的菌类和海藻粉末, 混合搅拌下加入上述药物辅助原科, 充分搅拌得一混合原 料, 灭菌;  (3) immersing the lactic acid aqueous solution for the Chinese herbal medicine powder for 24 hours, and then adding the pulverized fungi and seaweed powder, adding the above-mentioned drug-assisted progenitors under mixing and stirring, and thoroughly stirring to obtain a mixed raw material and sterilizing;
(4) 将 (3)所得到的混合原枓和菌草酸酶置于生物反应器中, 在 30-55 eC、 用乳酸调节 PH值至 4.0-6.5, 通气培养 5-8天, 每天搅拌 1-2次, 并在开始发酵第 24小时开始, 每 24小时接入占主原料总重量 1-2¾的一种担子菌的原浆和 / 或海藻 浆的混合物, 接种次数为 2 -3次, 得发酵产物; (4) Put the mixed protoplast and bacterial oxalase obtained in (3) in a bioreactor, adjust the pH to 4.0-6.5 with lactic acid at 30-55 e C, and culture for 5-8 days with aeration, stirring daily 1-2 times, and starting at the 24th hour of fermentation, every 24 hours, a mixture of a basidiomycete puree and / or seaweed pulp that accounts for 1-2¾ of the total weight of the main raw material is infused, and the number of inoculations is 2-3 times To obtain a fermentation product;
(5) 将上述发酵产物离心弃渣、 吸附脱色、 浓缩、 干燥后制成产品。  (5) Centrifuging and discarding the fermentation product, decolorizing it by adsorption, concentrating, and drying it to make a product.
其中各种原枓的选择及其用量具有与上述相同的定义。 所述的各种菌草酸酶 按如下方法制备:  The choice of various kinds of raw materials and their amounts have the same definition as above. The various bacterial oxalase enzymes are prepared as follows:
所述的 0!-淀粉酶来源于玉米淀粉 2 , 玉米浆 26*, 磷酸氢二钠 37*, 氟化钙 The 0! -Amylase is derived from corn starch 2, corn slurry 26 *, disodium hydrogen phosphate 37 *, calcium fluoride
1%, 氟化钾 0.2¾、 氟化镆 0.2%, 麸皮 9%, 红曲 猪胰一条的培养产物, 其中的 百分比为重量百分比; 1%, potassium fluoride 0.2¾, hafnium fluoride 0.2%, bran 9%, red yeast rice culture product of pig pancreas, where the percentage is weight percentage;
所述的真菌蛋白酶来源于玉米淀粉 30¾, 玉米浆 5*, 大豆粉 5¾, 酪蛋白 明胶 干酒糟 5¾ί, 磷酸二氪钾 2.4%, 硝酸钠 1 氣化铵:^、 琉酸铁 0.01 麸 皮 5*, 细糠 5*, 炅芝孢子粉 红曲 ½的培养产物, 其中的百分比为重量百分比; 所述的纤维素酶来源于食用菌绿色废菌枓 65¾ί, 麸皮 10%, 细糠 10 琉酸铵 2. 5%, 水 250%, 酵母贵 1 吐温 80 .0.05%, 粗红糖 1 红曲 1*的固体发酵产物, 其 中的百分比为重量百分比;  The fungal protease is derived from corn starch 30¾, corn slurry 5 *, soy flour 5¾, casein gelatin dried distiller's grains 5¾, dipotassium phosphate 2.4%, sodium nitrate 1 ammonium gasification: ^, iron sulphate 0.01 bran 5 *, Fine bran 5 *, culture product of Ganoderma spore pink koji ½, wherein the percentage is weight percentage; the cellulase is derived from edible fungus green waste fungus 65¾ί, bran 10%, bran 10 lucic acid Solid fermentation product of ammonium 2.5%, water 250%, yeast expensive 1 Tween 80.0.05%, crude brown sugar 1 red yeast rice 1 *, the percentage of which is weight percentage;
或来源于米糠 1%、 麸皮 0.5 琉酸铵 0.2 磷酸二氢钾 0.1、 碳酸钙 0.1%、 葡荀糖 1*在三角瓶中、 30eC、 104转 /分、 培养 32-35小时, 得种子一级发酵产物; 将废菌料 6 麸皮 0.5¾、 葡荀糖 琉酸铵 0.2 磷酸二氢鉀 0.1%在 30eC、 104 转 /分、 培养 60小时, 得种子二级培养物; 将种子一级、 二级培养物、 蛋白胨 0 .075%, 吐温 80 0.2%, 琉酸铵 1.4g/I 磷酸二氢钾 S.Og/L 尿素 O g/Is 氣化钙 0.3g/ L, 琉酸镁 0.3g/I 琉酸铁 5.(^/ 琉酸锰 l g/ 琉酸锌 l g/ 氣化 钴 2.09/1^ 并以分子量为 2000的聚丙二酵作消泡剂所进行的浪体发酵的产物, 其 中的百分比为重量百分比; Or derived from rice bran 1%, bran 0.5 ammonium sulphate 0.2 potassium dihydrogen phosphate 0.1, calcium carbonate 0.1%, glucomannose 1 * in a triangle flask, 30 e C, 104 rpm, culture 32-35 hours, The first-stage fermentation product of the seed was obtained; the waste fungus material 6 bran 0.5¾, glucosamine ammonium gluconate 0.2% potassium dihydrogen phosphate 0.1% were at 30 e C, 104 Turn / min and culture for 60 hours to obtain a secondary seed culture; seed primary and secondary cultures, peptone 0.075%, Tween 80 0.2%, ammonium sulphate 1.4g / I potassium dihydrogen phosphate S. Og / L urea O g / Is gasification calcium 0.3g / L, magnesium sulfur 0.3g / I ferric sulfur 5. (^ / manganese LG sulfur / sulfur LG zinc / cobalt gasifier 9 2.0 / 1 ^ and Wave body fermentation product using polymalonate having a molecular weight of 2000 as an antifoaming agent, wherein the percentage is a weight percentage;
所述的果胶酶来源于果胶 4%、 蛋白胨 0.4 琉酸钠 0.05%、 琉酸铁 0.01、 琉 酸镁 0.05 氣化钾 0.05%、 磷酸二氢钾 麸皮 5¾、 细糠 5%、 蔗糖 2%、 硝酸铵 0.2%, 硝酸钠 0.2 并接入合有 2 103个孢子的炅芝孢子悬浮浪, 30-C, 在三角 烧瓶中培养 7 天得到的培养产物, 其中的百分比为重量百分比。 The pectinase is derived from 4% of pectin, 0.4% of peptone, 0.05% of sodium sulphate, 0.01% of iron sulphate, 0.05% of magnesium sulphate, 0.05% of potassium vaporization, 55% of potassium dihydrogen phosphate bran, 5% fine bran, sucrose 2%, ammonium nitrate 0.2%, sodium nitrate 0.2 and connected to the spore suspension wave of ganoderma spores containing 2 10 3 spores, 30-C, culture product obtained by culturing in a conical flask for 7 days, where the percentage is weight percentage .
本发明的上述制备方法使得在制备过程中, 中草药中一些成分能够得到改变, 即改变了药物成分分子结'构, 使之能最有效地发挥各原科劝效, 而使制备的药物 具有多劝能保健劝效并对玫克某些疑难病症有一定疗欵, 且制备步骤筒单易行。  The above preparation method of the present invention enables some ingredients in Chinese herbal medicines to be changed during the preparation process, that is, the molecular structure of the drug components is changed, so that it can most effectively exert the persuasion of the original subjects, so that the prepared medicine has more It is suggested that health care can be effective, and some difficult diseases of Meike are treated, and the preparation steps are simple and easy.
以下对本发明进行详细说明。 '  The present invention is described in detail below. '
本发明的生物发酵物, 优选为如下组合原科的发酵产物, 其制备方法中使用 的各组分以原料的总重量计具有如下的重量百分数:  The biological fermentation product of the present invention is preferably the following combined fermentation product of the original family, and each component used in the preparation method thereof has the following weight percentages based on the total weight of the raw materials:
生物发酵物 ω:  Biological fermentation ω:
所述的担子菌与海藻类具有如下的重量百分数: 香菇 7-8¾, 佥针菇 18-19¾, 茯苓 1-2%, 炅芝 2-3 海带 14-16¾;  The basidiomycetes and seaweeds have the following weight percentages: Lentinus edodes 7-8¾, Flammulina velutipes 18-19¾, Poria 1-2%, Ganoderma 2-3 kelp 14-16¾;
所述的中草药具有如下重量百分数的组分: 柏子仁 7-8*, 蛇床子 3-4 菟丝 子 3-4 覆盆子 3-4%, 石斛 2-3%, 巴戟天 1-2 , 续断 4-5 乌药 0.5-1%, 菖蒲 1 -1.5%, 泽泻 0.5-1%, 山药 1-2 人参 1-2%, '熟地黄 2- 3 桑寄生 0.5-1%, 山茱 萸 1-1. 五味子 3-5%, 钟乳石 1-2¾, 肉苁蓉 2-3%和牛藤 0.7-1¾ί;  The Chinese herbal medicine has the following weight percentage components: Boziren 7-8 *, Shezizi 3-4 Cuscuta 3-4 Raspberry 3-4%, Dendrobium 2-3%, Morinda officinalis 1-2, Continued off 4-5 Black medicine 0.5-1%, Calamus 1-1.5%, Alisma 0.5-1%, Chinese yam 1-2 ginseng 1-2%, 'Rehmannia glutinosa 2- 3 mulberry parasitic 0.5-1%, Dogwood 1-1 Schisandra 3-5%, stalactites 1-2¾, Cistanche 2-3% and ox vine 0.7-1¾ί;
所述的辅助原料为具有如下重量百分数的组分: 蛋白胨 0.01-0.02%, 红糖 0 .2-0.3%, 石裔粉: 1 , KCI 0.4-0.5%, MgSO40. -0.5%, KH2PO40.4-0.5%, The auxiliary raw materials are components with the following weight percentages: peptone 0.01-0.02%, brown sugar 0.2-0.3%, stone powder: 1, KCI 0.4-0.5%, MgSO 4 0. -0.5%, KH 2 PO 4 0.4-0.5%,
(NH4)2SO40.3-0.35%; (NH 4 ) 2 SO 4 0.3-0.35%;
所述的菌草酸酶^由上述方法制成的纤维'素酶;  The bacterial oxalase ^ fiber's enzyme produced by the above method;
所述的用于接种的担子菌原浆和 / 或海藻浆的混合物依次为: 佥针菇原浆, 蘑菇原浆, 重量比为 2:1的炅芝和海带原浆。  The mixture of basidiomycete puree and / or seaweed puree used for inoculation is: Enoki mushroom puree, mushroom puree, Ganoderma lucidum and kelp puree with a weight ratio of 2: 1.
生物发酵物 (2):  Biological Ferment (2):
所述的担子菌与海藻类具有如下的重量百分数: 香菇 7-8%, 佥针菇 4-6 土 茯苓 1-2¾, 炅芝 2-3¾, 海带 7-8%;  The basidiomycetes and seaweeds have the following weight percentages: Shiitake mushrooms 7-8%, Enoki mushroom 4-6 soil Poria 1-2¾, Ganoderma 2-3¾, kelp 7-8%;
所述的中草药具有如下重量百分数的组分: 柏子仁 4-5*, 蛇床子 4-4.5 菟 丝子 4-4.5%, 覆盆子 4-4.5<fe, 石斛 1-1.5¾;, 巴戟天 1-1.5%, 杜仲 1-1.5 天门冬 1-1.5%, 志远(去心)1:1.5 ½:智仁 0.2-0.5 续断 0.5-0.7¾;, 乌药 0.5-0.7 苜蒲 0.7-1 泽泻 0.7-1S;, 山药 0.8-ί , 人参 0.8-1 熟地黄 0.5-0.8 山茱萸 S.6-1%, 五咮子 2-3 钟乳石(炼) 1-1.2¾;, 肉苁蓉 2-3 The Chinese herbal medicine has the following weight percentage components: Bo Zi Ren 4-5 *, She Chuang Zi 4-4.5 菟 Silk seeds 4-4.5%, raspberries 4-4.5 <fe, Dendrobium 1-1.5¾ ;, Morinda officinalis 1.-1.5%, Eucommia ulmoides 1-1.5 Asparagus 1-1.5%, Zhiyuan (heart removal) 1 : 1.5 ½: Zhiren 0.2-0.5 continuity 0.5-0.7¾ ;, Wuya 0.5-0.7 alfalfa 0.7-1 Alisma 0.7-1S ;, yam 0.8-ί, ginseng 0.8-1 rehmannia 0.5-0.8 dogwood S.6- 1%, Five Gardenias 2-3 Stalactites (refined) 1-1.2¾ ;, Cistanche 2-3
所述的辅助原科为具有如下重量百分数的组分: 麸皮 7-8%, 细糠 7-8 地瓜 粉 4-4.2%, 酵母 1-1.2¾f, 蔗糖 ;, 碳酸钙 1-1.2  The auxiliary progenitors are components having the following weight percentages: bran 7-8%, fine bran 7-8 sweet potato powder 4-4.2%, yeast 1-1.2¾f, sucrose, calcium carbonate 1-1.2
所述的菌草酸酶为上述方法制成的纤维素酶;  The bacterial oxalase is a cellulase made by the above method;
所述的用于接种的担子菌原浆和 / 或海藻浆的混合物依次为: 佥针菇原浆, 蘑菇原浆, 重量比为 2:1的炅芝和海带原浆。  The mixture of basidiomycete puree and / or seaweed puree used for inoculation is: Enoki mushroom puree, mushroom puree, Ganoderma lucidum and kelp puree with a weight ratio of 2: 1.
生物发酵物 (3):  Biological Ferment (3):
所述的担子菌与海藻类具有如下的重量百分数: 土茯苓 炅芝 7-8¾, 海 带 7-8¾;;  The basidiomycetes and seaweeds have the following weight percentages: Poria cocos, Potentilla 7-8¾, kelp 7-8¾;
所述的中草药具有如下重量百分数的组分: 何首乌(制) 5-6%、 怀牛膝 3-4¾、 菟丝子 3-4 女贞子 3-4%, 生杜仲 4-5 縣签草 5-6%, 桑叶 2-3%, 银花 3-4 %, 黑桑椹 3-4%, 枸杞子 0.3-0. , 菊花 5 -6% 地黄 3_4¾, 山萸肉 3-4¾, 丹皮 3_4%, 泽泻 0.3-0.4¾, 山药 3-4%; The Chinese herbal medicine has the following weight percentage components: Polygonum multiflorum (manufactured) 5-6%, Achyranthes bidentata 3-4¾, Cuscuta 3-4, Ligustrum 3-4%, Eucommia ulmoides 4-5, County sign grass 5- 6%, mulberry leaves 2-3%, silver flowers 3-4%, black mulberries 3-4%, medlar 0.3-0., Chrysanthemums 5 -6% Dihuang 3 _4¾, mangosteen 3-4¾, tannin 3 _ 4 %, Alisma 0.3-0.4¾, yam 3-4%;
所述的辅助原枓为具有如下重量百分数的组分: 麸皮 7- , 细糠 7-8%, 酵母 1-1.2%, 蔗糖 1-1.2%, 碳酸钙 1-1.2*;  The auxiliary raw tincture is a component having the following weight percentages: bran 7-, fine bran 7-8%, yeast 1-1.2%, sucrose 1-1.2%, calcium carbonate 1-1.2 *;
所述的菌草酸酶为 0.02*的纤维素酶和 0.01%的果胶酶;  The bacterial oxalase is 0.02 * cellulase and 0.01% pectinase;
所述的用于接种的担子菌原浆和 / 或海藻浆的混合物依次为: 香菇原浆, 蘑 菇原浆, 海带原浆。  The mixture of basidiomycete puree and / or seaweed puree used for inoculation is: shiitake mushroom puree, mushroom puree, kelp puree.
生物发酵物 "):  Biological Ferment "):
所述的担子菌与海藻类具有如下的重量百分数: 香菇 3- , 蘑菇 3-4%, 猴头 菇 3-«, 海带 5-6%;  The basidiomycetes and seaweeds have the following weight percentages: Lentinus 3-, Mushroom 3-4%, Hericium 3- «, Kelp 5-6%;
所述的中草药具有如下重量百分数的组分: 黄药子 10-20*, 川断 4-5*, 沙苑 子 4-5 牡蛎 3-4¾, 莪术 3-4%, 祧仁 3- , 川楝子 4-5 青皮 3 -4%, 蜈蚣 1.2-1 .5%, 斑 §1.2-1.5*, 滑石 3-4¾ί, 独角莲 3-4 砂仁 2-3¾!, 鸡佥内 2- 3%, 党参 2 -3%, 黄芪 3-6¾, 熟地黄 3-6*, '二丑 3-6½, 槟榔片 3-6%, 川军 1-2 元明粉 1-2 干蛤蟆 0.5-1*, 急性子 0.6-1, 2 竹茹 2·3<¾和代赭石 4-5*; The Chinese herbal medicine has the following weight percentage components: Huangyaozi 10-20 *, Chuandi 4-5 *, Shayuanzi 4-5, Oyster 3-4¾, Curcuma 3-4%, Coix Seed 3-, Chuanxiongzi 4 -5 green peel 3 -4%, 蜈蚣 1.2-1.5%, spot §1.2-1.5 *, talc 3-4¾ί, unicorn 3-4 amomum 2-3¾ !, chicken gizzard inside 2-3%, codonopsis 2 -3%, astragalus 3-6¾, cooked rehmannia 3-6 *, 'er ug 3-6½, betel nut slices 3-6%, Sichuan army 1-2 yuan Ming powder 1-2 dried toad 0.5-1 *, acute 0.6 -1, 2 Zhuru 2 · 3 <¾ and ochre 4-5 *;
所述的辅助原料为具有如下重量百分数的组分: 麸皮 4-5 细糠 4-5%, 酵母 1.2-1.5%, 红糖 3- , 黄豆粉 3- , 碳酸钙 1-1.2%;  The auxiliary raw materials are components having the following weight percentages: bran 4-5 fine bran 4-5%, yeast 1.2-1.5%, brown sugar 3-, soybean powder 3-, calcium carbonate 1-1.2%;
所述的菌草酸酶为 0.02¾的上述纤维素酶和 0.01%的上述果胶酶; 所述的用于接种的担子菌原浆和 / 或海藻浆的混合物依次为: 香菇原浆, 海 带原浆, 炅芝原浆。 The bacterial oxalase is 0.02¾ of the above-mentioned cellulase and 0.01% of the above-mentioned pectinase; The mixture of basidiomycete puree and / or seaweed puree used for inoculation is: shiitake mushroom puree, kelp puree, and ganoderma puree.
生物发酵物 (5):  Biological Ferment (5):
' 所述的担子菌与海藻类具有如下的重量百分数: 银耳 10-15%, 香菇 1.5-4.5 发菜 5- ; · ' ,  'The basidiomycetes and seaweeds have the following weight percentages: 10-15% Tremella, 1.5-4.5 Shiitake 5-;
所述的中草药具有如下重量百分数的組分: 玄参 3- , 麦冬 3- , 生地黄 3 -4%, 赤芍 1-2 丹皮 1-2S;, 黄芪 3-4%, 山药 3- , 祧仁 1-2*, 红花 1_2*, 柴胡 0· 5-0. 6*和海参 7-8%;  The Chinese herbal medicine has the following weight percentage components: Xuanshen 3-, Ophiopogon 3-, Raw Rehmannia 3-4%, Chiba 1-2 Danshen 1-2S ;, Astragalus 3-4%, Yam 3- , Coix 1-2 *, Safflower 1_2 *, Bupleurum 0.5-5-0. 6 * and sea cucumber 7-8%;
所述的辅助原料为具有如下重量百分数的组分: 麸皮 细糠 6-8 地瓜 粉 6-8%, 酵母 1.2-2¾, 蔗糖 1.2-2%, 碳酸钙 1-1.2  The auxiliary raw materials are components having the following weight percentages: bran fine bran 6-8 sweet potato powder 6-8%, yeast 1.2-2¾, sucrose 1.2-2%, calcium carbonate 1-1.2
所述的菌草酸酶为 0. 02*的上述纤维素酶和 0. 01%的上述果胶酶;  The bacterial oxalase is 0.02 * of the above-mentioned cellulase and 0.01% of the above-mentioned pectinase;
所述的用于接种的担子菌原浆和 / 或海藻浆的混合物依次为: 香菇原浆, 海 带原浆, 炅芝原浆。  The mixture of basidiomycete puree and / or seaweed puree used for inoculation is: shiitake mushroom puree, kelp puree, and ganoderma puree.
生物发酵物 (6):  Biological Ferment (6):
所述的担子菌与海藻类具有如下的重量百分数: 香菇 2-3 猪苓 1-2¾, 茯苓 4-5%, 海带 4-5 ; . .  The basidiomycetes and seaweeds have the following weight percentages: Lentinus 2-3, Poria cocos 1-2¾, Poria cocos 4-5%, Kelp 4-5;..
所述的中草药具有如下重量百分数的组分: 黄芪 1-2 党参 1-2*, 防已 1-2 白术 1-2 生首乌 2-4*, 泽泻 4-8 山楂 2-4 茵陈 2-4%, 水牛角 2-4*, 淫羊藿 2-4*和大黄  The Chinese herbal medicine has the following weight percentage components: Astragalus 1-2, Codonopsis 1-2 *, Fangfang 1-2, Atractylodes 1-2, Shouwu 2-4 *, Zexie 4-8, Hawthorn 2-4, Yinchen 2-4%, buffalo horns 2-4 *, epimedium 2-4 * and rhubarb
所述的辅助原料为具有如下重量百分数的組分: 麸皮 10-12%, 细糠 5-6¾, 地 瓜粉 5-6%, 面包酵母 1-1.2 红糖 1-1.2*, 碳酸钙 1-1.2*;  The auxiliary raw materials are components having the following weight percentages: bran 10-12%, fine bran 5-6¾, sweet potato flour 5-6%, baker's yeast 1-1.2 brown sugar 1-1.2 *, calcium carbonate 1-1.2 *;
所述的菌草酸酶为 0. 02¾;的上述纤维素酶 O0. 01*的上述真菌蛋白酶; 所述的用于接种的担子菌原浆和 / 或海藻浆的混合物依次为: 香菇原浆, 蘑 菇原浆, 紫菜原浆。  The bacterial oxalase is 0.002¾; the above-mentioned cellulase O. 01 * ’s fungal protease; the mixture of basidiomycete puree and / or seaweed puree used for inoculation is: shiitake puree, Mushroom puree, seaweed puree.
生物发酵物 (7):  Biological Ferment (7):
所述的担子菌与海藻类具有如下的重量百分数: 香菇 15-20%, 海带  The basidiomycetes and seaweeds have the following weight percentages: shiitake mushrooms 15-20%, kelp
所述的中草药具有如下重量百分数的组分: 何首乌 18-22¾;, 女贞子 9-10* , 怀山药 9-10%, 桑椹 和杭白菊 3· ; The Chinese herbal medicine has the following weight percentage components: Polygonum multiflorum 18-22¾ ;, Ligustrum lucidum 9-10 *, Huai yam 9-10%, Mulberry and Hangbaiju 3 ·;
所述的辅助原料为具.有如下重量百分数的组分: 麸皮 10-12^ 细糠 5-6¾, 酵 母 1-1.2*, 红糖 1.5-2· 5*, 碳酸钙 1-1.2*;  The auxiliary raw material is a component having the following weight percentages: bran 10-12 ^ fine bran 5-6¾, yeast 1-1.2 *, brown sugar 1.5-2 · 5 *, calcium carbonate 1-1.2 *;
所述的菌草酸酶为 0.02*的上述纤维素酶和 0.03Λ的上述淀粉酶;  The bacterial oxalase is the above-mentioned cellulase of 0.02 * and the above-mentioned amylase of 0.03Λ;
所述的用于接种的担子菌原浆和 / 或海藻浆的混合物依欢为: 炅芝原浆, 佥 针菇原浆, 海带原浆。 The mixture of basidiomycete puree and / or seaweed puree used for inoculation is: Zhizhi puree, 佥 Needle mushroom puree, kelp puree.
本发明中使用的菌草酸酶为永解酶, 但将巿售的水解酶纯品用于本发明, 效 果不好, 其原因在于这些酶主要是由真菌产生的, 很难对中草药进行有效的分解。 本发明中的菌草酸酶是真菌和組菌共同发酵产生的, 使用时以上述的纤维素酶为 主, 或从上述的淀粉酶、 果胶酶、 蛋白酶中选出一种与上述的纤维素酶共同使用。  The bacterial oxalase used in the present invention is a permanganase, but the pure hydrolyzed enzymes sold in the present invention are not effective because the enzymes are mainly produced by fungi and it is difficult to effectively treat Chinese herbal medicines. break down. The bacterial oxalase in the present invention is produced by co-fermentation of fungi and group fungi. When used, the above-mentioned cellulase is mainly used, or one of the above-mentioned cellulose is selected from the above-mentioned amylase, pectinase, and protease. Enzymes are used together.
本发明的制备方法中各步骤详述如下。  Each step in the preparation method of the present invention is described in detail below.
1 、 原料选取: . . .  1. Raw material selection:...
本发明担子菌类、 藻类、 中草药均选用弃除杂质的干品, 并按配方称取各原 料重量。 · , ' · ' ,  The basidiomycetes, algae, and Chinese herbal medicines of the present invention are all dry products with impurities removed, and the weight of each raw material is weighed according to the formula. ·, '·',
2、 粉碎磨粉:  2. Crushing and grinding powder:
上述菌类、 藻类分别粉碎磨成粉末, 中草药粉碎成 1 6 - 2 0 目细度粉状体。  The above fungi and algae are pulverized and ground into powder, respectively, and the Chinese herbal medicine is pulverized into a 16-20 mesh fineness powder.
3 、 酸化处理:  3, acidification treatment:
先将中草药粉粒用 1 5 %浓度乳酸浸泡 2 4 小时, 后加入菌类和海藻粉末。  Soak the Chinese herbal medicine powder with 15% lactic acid for 24 hours, and then add the fungus and seaweed powder.
4、 混合搅拌:  4. Mixing:
在半上述各原料混合搅拌状况下, 再掺入各辅助原科产酶促进剂, 氨源, 碳 源及营养添加剂后混合搅拌均匀。  In the state of mixing and stirring each of the above raw materials, the enzyme promoter, ammonia source, carbon source, and nutritional additive of each auxiliary original product are further mixed, and then mixed and stirred evenly.
5 、 接种发酵: ,  5. Inoculation fermentation:,
本发明釆用液体深层通气发酵法制作, 先将上述已充分混合的原枓置于生物 反应器, 发酵温度 3 0 "C - 5 5 V, 用乳酸调节 p H值至 4 .0 - 6 .5 , 发酵时 间 5 - 8 天, 每天搅拌 1 " 2 次。 从开始发酵 2 4 小时起, 以 2 4 小时为间隔每 次接入占配方总重量的 1 - 2 %—种担子菌原浆和 / 或海藻原浆的混合物。  The present invention is produced by a liquid deep aeration fermentation method. The above-mentioned fully-mixed raw soup is first placed in a bioreactor, the fermentation temperature is 30 "C-5 5 V, and the p H value is adjusted to 4.0-6 with lactic acid. 5, fermentation time 5-8 days, stirring 1 "2 times a day. 24 hours from the start of fermentation, a mixture of 1-2% of the basidiomycete puree and / or seaweed puree is added at intervals of 24 hours.
6 、 离心弃渣: ■ ' ,  6. Centrifugal waste residue: ■ ',
将上述经发酵的混合物置于超速离心机, 转子温度控制在 0。 - 5 ·(:之间, 离心时间 1 0 分钟 / 次, 取上清浪, 将离心获得渣加乳酸浸提 2 4 小时再次超速 离心, 得上清浪, 合并二次上清 离心后的原枓渣可作饲科添加剂使用。  The fermented mixture was placed in an ultracentrifuge, and the temperature of the rotor was controlled at zero. -5 · (: between, centrifugation time 10 minutes / times, take the clear wave, centrifuge the slag plus lactic acid to extract for 24 hours and ultracentrifuge again to get the clear wave, combine the original supernatant after the second supernatant centrifugation Dregs can be used as feed additives.
7、 吸附脱色:  7. Adsorption and decolorization:
将两获得上清液用孔径 1 8 λ - 2 0 Α活性炭吸附, 去除不饱和脂肪酸并脱 色。  The two obtained supernatants were adsorbed with a pore size 18 λ-2 A activated carbon, and unsaturated fatty acids were removed and decolorized.
8 、 浓缩:  8. Concentration:
将已经脱色处理的上清浪用脱水机浓缩成合水量为 3 0 - 3 5 %的胶状体。  The decolorized supernatant water is concentrated by a dehydrator to a gelatinous body with a combined water content of 30-35%.
9 、 干燥:  9. Drying:
将上述的胶状体置于自动调温干燥箱干燥, 温度控制在 5 5 - 7 5 eC之间干 燥 4 小时得合水量至 5. "8 %的粉剂成品。 > , Put the above gel in a temperature-controlled drying oven to dry, the temperature should be controlled between 5 5-7 5 e C Dry for 4 hours to get the water content to 5. "8% powder finished product.>,
1 0、 成品包装:  1 0. Finished product packaging:
将粉剂成品以 1 0 mg / 瓶真空包装成瓶装。  The finished powder product is vacuum packed into bottles at 10 mg / bottle.
下面通过具体的实例描述本发明的制备方法。 本发明的最佳实施方式 参考例 1  The preparation method of the present invention is described below through specific examples. Best Mode for Carrying Out the Invention Reference Example 1
α -淀粉酶的制备  Preparation of alpha-amylase
对玉米淀粉 24 玉米浆 26 ¼酸 二钠 37*, 氯化钙 1 氟化钾 0.2¾, 氯 化镁 0.2%, 麸皮 , 红曲 1% (其中的百分比为重量百分比) , 猪胰一条进行通气 发酵, 发酵时间为 72小时, 温度 37±leC, PH值为 6.0-7.0。 其培养产物中合有 α 淀粉酶 30%的干物。 ' 參考例 2 ' Corn starch 24 corn syrup 26 ¼ disodium 37 *, calcium chloride 1 potassium fluoride 0.2¾, magnesium chloride 0.2%, bran, red yeast rice 1% (the percentage of which is weight percentage), the pig pancreas is aerated and fermented The fermentation time is 72 hours, the temperature is 37 ± l e C, and the pH value is 6.0-7.0. The culture product contains 30% of the dried amylase. `` Reference Example 2 ''
真菌蛋白酶的制备  Preparation of fungal protease
取玉米淀粉 30 玉米浆 5*, 大豆粉 5¾, 酪蛋白 明胶 5%, 干洒糟 5%, 磷 酸二氢鉀 2.4%, 硝酸钠 1 氟化铵 1%、 琉酸铁 0.01 麸皮 5%, 细糠 5 炅芝孢 子粉 , 红曲 1* (其中的百分比为重量百分比) 进行通气发酵, 发酵时间 48小时, 温度 34士 1"C, pH值为 6.0-7.0。 其培养产物中合有真菌蛋白酶 30%的结晶。 参考例 3 - A  Take corn starch 30, corn slurry 5 *, soy flour 5¾, casein gelatin 5%, dry sprinkler 5%, potassium dihydrogen phosphate 2.4%, sodium nitrate 1 ammonium fluoride 1%, iron ferrite 0.01 bran 5%, Fine bran 5 Ganoderma lucidum spore powder, red yeast rice 1 * (the percentage of which is weight percentage) is aerated fermentation, the fermentation time is 48 hours, the temperature is 34 ± 1 "C, and the pH value is 6.0-7.0. The culture product contains fungi 30% crystallization of protease.Reference Example 3-A
纤维素酶的制备  Preparation of cellulase
取食用菌绿色废菌料 65 麸皮 10¾, 细糠 10*, 琉酸铵 2.5¾ί, 永 250%, 酵母 #1%, 吐温 80 0.05%, 粗红糖 1*, 红曲 1* (其中的百分比为重量百分比) 的固体 发酵, 发酵时间 144小时, '温度 40±1'C, pH值为 4.0-5.0。 其培养产物中纤维素 酶的合量为 4-5%的干重。 参考例 3 -B Take edible fungus green waste fungus material 65 bran 10¾, fine bran 10 *, ammonium sulphate 2.5¾, Yong 250%, yeast # 1%, Tween 80 0.05%, crude brown sugar 1 *, red yeast rice 1 * (of which The percentage is weight percentage) of solid fermentation. The fermentation time is 144 hours, the temperature is 40 ± 1'C, and the pH is 4.0-5.0. The total amount of cellulase in the culture product is 4-5% dry weight. Reference example 3 -B
纤维素酶的制备  Preparation of cellulase
取米糠 1 麸皮 0.5 琉酸铵 0.2%、 磷酸二 甲 0.1¾、 碳酸钙 0.1%、 葡萄糖 Take rice bran 1 bran 0.5 ammonium laurate 0.2%, dimethyl phosphate 0.1¾, calcium carbonate 0.1%, glucose
1% (其中的百分比为重量百分比) 在三角瓶中、 30°C, 104转 /分、 培养 32-35 小 时, 得种子一级发酵产物; 将废菌料 6 麸皮 0,5 葡萄糖 1 琉酸铵 ο· 2 磷 酸二氢钾 0.1*在 30· (:、 104转 /分、 培养 60小时, 得种子二级培养物; 将种子一级、 二级培养物、 蛋白胨 0.07.5 吐温 80 0.2、 琉酸铵 1.4g/I 磷酸二氪鉀 Og/I^ 尿素 o.3g/i 氣化钙 o.3g/∑s 琉酸镁 Q.¾/i 锍酸铁 5.ogA 硫酸猛 i.6g/L、 旒酸锌 1.4g/ 氣化钴 2.0g/Lj 并以分子量为 2000的聚丙二醇作消泡剂所进行的 浪体发酵的产物; 其中纤维素酶的合量为 6.3_7.0%的干重。 參考例 4 1% (wherein the percentage is weight percentage) in a Erlenmeyer flask, 30 ° C, 104 rpm, culture 32-35 hours The first-stage fermentation product of the seed is obtained; the waste fungus material 6 bran 0, 5 glucose 1 ammonium luteate ο · 2 potassium dihydrogen phosphate 0.1 * at 30 · (:, 104 rpm, culture 60 hours, and Seed secondary culture; seed primary, secondary culture, peptone 0.07.5 Tween 80 0.2, ammonium sulphate 1.4g / I dipotassium phosphate Og / I ^ urea o. 3g / i calcium carbonate o 3 g / ∑s magnesium sulphate Q.¾ / i iron osmate 5. ogA sulphate i. 6 g / L, zinc osmate 1.4 g / cobalt gasification 2.0 g / Lj and polypropylene glycol with molecular weight 2000 the product as body waves defoamer for fermentation; wherein the amount of cellulase together is 63 _ 7.0% dry weight reference Example 4.
果胶酶的制备  Preparation of pectinase
取果胶 (胡萝卜、 柑档、 昝茄、 苹果、 香蕉等果汁) 4 蛋白胨 0. 、 旒酸 钠 0.05¾、 琉酸铁 0.01%、 旒酸镁 0.05¾、 氟化钾 0.05¾、 磷酸二氢钾 0.1 %, 麸皮 5%, 细糠 5 蔗糖 2 硝酸铵 0.2 硝酸钠 0.2% (其中的百分比为重量百分比) , 并接入合有 2X103个孢子的炅芝孢于悬浮浪, 30eC 在 1 0 O ml 三角烧瓶中装Take pectin (carrot, mandarin orange, eggplant, apple, banana and other fruit juices) 4 peptone 0.1, sodium gallate 0.05¾, iron sulphate 0.01%, magnesium gallate 0.05¾, potassium fluoride 0.05¾, dihydrogen phosphate Potassium 0.1%, bran 5%, fine bran 5 sucrose 2 ammonium nitrate 0.2 sodium nitrate 0.2% (wherein the percentage is weight percentage), and connected with 2 × 10 3 spores of ganoderma lucidum in suspension waves, 30 e C Fill a 10 O ml Erlenmeyer flask
3 0 ml , 培养 7 天。 得到的培养产物中果胶酶的合量为 15-20%。 实施例 1 . . 30 ml for 7 days. The total amount of pectinase in the obtained culture product is 15-20%. Example 1.
取担子菌类和海藻: 香菇 4 4 0 g , 佥针菇 1 1 0 g 、 茯苓 1 1 0 g , 炅芝 22 0 g , 海带 2 2 O.g ;  Take basidiomycetes and seaweed: 440 g of Lentinus edodes, 110 g of Flammulina velutipes, 110 g of Poria cocos, 20 g of Ganoderma lucidum, 2 2 O.g of kelp;
取中草药: 柏子仁 2 3 0 g , 蛇床子 1 1 0 g , 菟丝子 1 1 0 g ., 覆盆子 1 1 0 g , 石斛 7 5 g , 巴戟天 45 g , 杜仲 9 0 g , 天门冬 9 0 g , 远志 7 0 g, 益智仁 1 5 g , 续断 1 45 g , 乌药 3 0 g , 菖蒲 4 0 g , 泽泻 3 0 g , 山药 4 0 g , 人参 4 0 g , 熟地黄 6 0 g , 桑寄生 20 g , 山茱萸 3 0 g , 五味子 1 2 0 g , 钟乳石 4 0 g , 肉苁蓉 90 g, 牛藤 20 g ;  Chinese herbal medicines: Bo Ziren 230 g, Snake Bed 110 g, Cuscuta 110 g., Raspberry 110 g, Dendrobium 75 g, Morinda officinalis 45 g, Eucommia 90 g, Asparagus 9 0 g, Polygala spp. 70 g, Zhiren Kernel 15 g, Continuity 1 45 g, Black medicine 30 g, Calamus 40 g, Alisma 30 g, Yam 40 g, Ginseng 40 g, Rehmannia glutinosa 60 g, mulberry parasitic 20 g, dogwood 30 g, schisandra 12 g, stalactite 40 g, cistanche 90 g, oxgrass 20 g;
取辅助成分: 酵母 *5 . 5 g , 蛋白胨 5 . 5 g , 红糖 1 3 7 · 5 g , 石裔 粉 1 .3 75 g, KC1 1 .3 75 g , MgSO40 .275 g , KH2P040 .2 75 g g , ( HJ2S040 .8 2 g ; Auxiliary ingredients: Yeast * 5.5 g, Peptone 5.5 g, Brown sugar 1 37 · 5 g, Shi Yi powder 1.35 g, KC1 1.3 g, MgSO 4 0 .275 g, KH 2 P0 4 0 .2 75 gg, (HJ 2 S0 4 0 .8 2 g;
取菌草酸酶参考例 3 - A的纤维素酶 0 : 0 8 7 g ;  Take the cellulase of Reference Example 3-A of oxalase 0: 0 8 7 g;
佥针菇原浆 0 - 8 7 g ; 蘑菇原浆 0 . 43 5 g ; 炅芝与海带 (1 : 1 ) 的 原浆 0 . 65 g。  Flammulina velutipes puree 0-8 7 g; mushroom puree 0.43 5 g; puree of ganoderma and kelp (1: 1) 6.5 g.
将菌类和海藻类粉碎成粉末状, 中草药混合粉碎成 1 8 目细度粉 先将中 草药置于 1 5 9 &的乳睐水溶液中浸泡 24 小时; 后加入食用菌和海带粉末, 混合 搅拌均匀, 再加入辅助原料酵母胬, 蛋白胨、 红糖、 石赍粉, KC1 , Mg S O Crush the fungus and seaweed into powder, mix and pulverize the Chinese herbal medicine into 1 8 mesh fine powder, first soak the Chinese herbal medicine in a 159 & milk solution for 24 hours; then add the edible fungus and kelp powder, mix and stir well Then add auxiliary raw materials yeast peptone, peptone, brown sugar, stone powder, KC1, Mg SO
4, H2 P , (NH^ ) 2 S C 等充分混合搅拌 8 分钟。 将上述混合物 灭菌后置于生物反应器中, 加入菌草酸酶发酵, 用乳酸调节 P H值 5 , 通气培养, 发酵温度为 4 0 发酵时间为 6 天, 每天搅拌 2 次, 在开始发酵后 2 4 小时接 入配方总重量 2 %的佥针菇原浆, 在发酵 4 8 小时时接入配方总重量 2 %的磨菇 原浆, 在发酵的 7 2 小时接入配.方总重的 1 , 5 %炅芝和磨菇原浆。 将已发酵的 混合物置于超迷离心机控制在 2 'C离心 1 0 分钟, 取上清浪, 将离心后的渣加乳 酸浸提 2 4 小时, 置离心机离心 1 0 分钟, 合并二次上清液, 用孔径 1 8 A活性 炭吸附, 除去不饱中脂.肪齩并脱色后, 再经脱水机浓缩成合水量 3 5 %的胶状体, 再置于调温干燥箱在 6 0 C左右干燥 4 小时, 制成合永量 6 %的粉剂成品 2 k g 。 实施例 2 4, H 2 P, (NH ^) 2 SC, etc. were thoroughly mixed and stirred for 8 minutes. Put the above mixture Placed in the bioreactor after sterilization, the enzyme was added oxalic acid bacteria fermentation with lactic acid to adjust the PH value of 5, aeration culture, the fermentation temperature is 40 fermentation time was 6 days, 2 times a day with stirring, in 24 hours after the start of fermentation contact Add 2% of the enoki mushroom puree to the formula, and add 2% of the mushroom puree to the formula during 48 hours of fermentation, and add 1 to 5% of the formula's total weight within 7 to 2 hours of fermentation. Puree of Ganoderma and Mushroom. The fermented mixture was centrifuged in an ultra-centrifuge centrifuge at 2 'C for 10 minutes, and the clear water was taken. The centrifuged residue was leached with lactic acid for 24 hours. The centrifuge was centrifuged for 10 minutes and combined twice. The clear solution is adsorbed with activated carbon with a pore size of 18 A to remove the unsaturated medium fat. After the fat is decolorized, it is concentrated by a dehydrator to a colloid with a water content of 35%, and then placed in a temperature-controlled drying box at about 60 C. Dry for 4 hours to make 2 kg of powdered finished product with a total volume of 6%. Example 2
取担子菌与海藻类: 香菇 7 0 g , 佥针菇 6 0 g , 土茯苓 1 0 g , 炅芝 3 0 g , 海带 7 0 g;  Take basidiomycetes and seaweed: 70 g of Lentinus edodes, 60 g of Flammulina velutipes, 10 g of Poria cocos, 30 g of Ganoderma lucidum, and 70 g of kelp;
取中草药: 柏子仁 4 0 g , ^床子 4 5 g , 菟丝子 4 0 g , 覆盆子 4 5 g , 石斛 1 0 g , 巴戟天 1 5 g , 杜仲 1 0 g , 天门冬 1 5 g , 志远 (去心)1 0 g , 益智仁 5 g , 续断 5 g , 乌药 7 g , 菖蒲 1 0 g , 泽泻 7 g , 山药 1 0 g , 人参 8 g , 熟地黄 8 g , 山茱萸 6 g , 五咮子 3 0 g , 钟乳石(炼) 1 2 g , 肉苁蓉 2 Take Chinese herbal medicines: Bozi Ren 40 g, 床 bed 45 g, Cuscuta 40 g, Raspberry 45 g, Dendrobium 10 g, Morinda officinalis 15 g, Eucommia 10 g, Asparagus 15 g, Zhi Far (heart-free) 10 g, Noir kernel 5 g, Intermittent 5 g, Black medicine 7 g, Acorus 10 g, Alisma 7 g, Yam 10 g, Ginseng 8 g, Rehmannia glutinosa 8 g, Dogwood 6 g, 30 g of five gardenia seeds, stalactite (refined) 1 2 g, cistanche 2
0 g ; 0 g;
取辅助原料: 麸皮 7 0 g , 细糠 8 0 g , 地瓜粉 4 0 g , 酵母 1 2 g , 蔗糖 Auxiliary ingredients: 70 g of bran, 80 g of fine bran, 40 g of sweet potato powder, 12 g of yeast, sucrose
1 0 g , 碳酸钙 1 2 g ; 10 g, calcium carbonate 12 g;
取菌草酸酶为參考例 3 - B制成的纤维素癣0 . 3 g ; 3 g of cellulose ringworm made from Reference Example 3 -B
用于接种担子菌原浆和 / 或海藻原浆的混合物依次为: 佥针菇原浆 0 . 1 6 g , 蘑菇原浆 0 . 0 8 g , 灵芝和海带 (1 : 1 ) 原浆 0 . 0 9 g 。  The mixture used to inoculate the basidiomycete puree and / or seaweed puree is: 0.16 g puree of mushrooms, 0.08 g of puree of mushrooms, ganoderma and kelp (1: 1) puree 0. 0 9 g.
重复实施例 1 的方法, 制成合水量 6 %的粉剂成品 3 0 0 g。  The method of Example 1 was repeated to produce 300 g of a powder finished product with a water content of 6%.
该产品主治肾虛, 肝郁火, 脾气不足。 实施例 3  This product treats kidney deficiency, liver stagnation and fire, and lack of temper. Example 3
取担子菌与海藻类: 土茯苓 7 0 g , 炅芝 8 0 g , 海带 7 0 g ;  Take basidiomycetes and seaweeds: 70 g of Poria cocos, 80 g of Ganoderma lucidum and 70 g of kelp;
取中草药: 何首乌(制) 5 0 g、 怀牛膝 4 0 g、 菟丝子 3 0 g , 女贞子 4 0 g , 生杜仲 4 0 g , 豕希莶草 6 0 g , 桑叶 2 0 g , 银花 4 0 g , 黑桑椹 4 0 g , 枸杞子 4 g , 菊花 6 0 g , 地黄 4 0 g , 山 肉 3 0 g , 丹皮 4 0 g , 泽泻 4 g , 山药 4 0 g ;  Chinese herbal medicine: Polygonum multiflorum (manufactured) 50 g, Austrodia chinensis 40 g, Cuscuta chinensis 40 g, Ligustrum lucidum 40 g, Eucommia ulmoides 40 g, Agaricus syringa 60 g, Mulberry leaf 20 g, 40 g of silver flower, 40 g of black mulberry, 4 g of wolfberry, 60 g of chrysanthemum, 40 g of rehmannia glutinosa, 30 g of yam meat, 40 g of tannin, 4 g of diarrhea, and 40 g of yam;
取辅助原枓: 麸皮 7 0 g , 细糠 8 0 g , 酵母 1 2 g , 蔗糖 1 2 g , 碳酸钙 取菌草酸酶为参考例 3 - A制成的钎维'素酶 0 . 2 g 和参考例 4 制成的果胶 薛 0 . 1 g ; Extraction of auxiliary raw materials: 70 g of bran, 80 g of fine bran, 12 g of yeast, 12 g of sucrose, calcium carbonate Take bacillary oxidase as the brazillin 'enzyme enzyme 0.2 g made in Reference Example 3-A and pectin Xue 0.1 g made in Reference Example 4;
用于接种的担子菌原浆和 / 或海藻原浆的混合物依次为: 香菇原浆 0 . 1 6 g , 蘑菇原浆 0 - 1 6 g , 海带原浆 0 · 0 9 gThe mixture of basidiomycete puree and / or seaweed puree used for inoculation is: 0.16 g of mushroom puree, 0-16 g of mushroom puree, and 0 · 0 9 g of kelp puree.
重复实施例 1 的方法, 制成合水量为 6 9 &的粉剂成品 9 4 0 g。  The method of Example 1 was repeated to prepare a powder finished product with a water content of 6 9 & 9 4 0 g.
该产品能宁血养阴, 化瘀通络, 降低血脂。 实施例 4  This product can calm blood and nourish yin, dissipate blood stasis and clear collaterals, and lower blood lipids. Example 4
取担子菌与海藻类: 香菇 4 .0 g , 蘑菇 0 g , 猴头菇 4 0 g , 海带 6 0 g, 海藻 4 0 g ;  Take basidiomycetes and seaweed: 4.0 g of shiitake mushrooms, 0 g of mushrooms, 40 g of Hericium erinaceus, 60 g of kelp, and 40 g of seaweed;
取中草药: 黄药子 1 0 0 g , 川断 5 0 g , 沙苑子 5 0 g , 牡蛎 4 0 g , 莪 术 4 0 g , 祧仁 4 0 g , .川楝子 4 0 g , 青皮 3 0 g , 蜈蚣 6 条, 斑 ¾6 条, 清 石 3 0 g , 独角莲 3 0 g , 砂仁 2 0 g , 鸡佥内 2 0 g , 党参 2 0 g , 黄芪 6 0 g , 熟地黄 6 0 g , 二丑 3 0 g , 槟榔片 4 δ g , 川军 1 5 g , 元明粉 1 5 g , 干蛤嫫 8 g , 急性子 1 0 g , 竹茹 2 0 g 和代赭石 4 5 g ;  Take Chinese herbal medicine: 100 g of yellow medicine, 50 g of chuanchuan, 50 g of shayuanzi, 40 g of oysters, 40 g of zedoary turmeric, 40 g of coix seed, 40 g of chuanxiongzi, 30 g of green peel,蜈蚣 6 bars, ¾6 bars, Qingshi 30 g, unicorn 30 g, Amomum villosum 20 g, chicken gizzard 20 g, codonopsis 20 g, astragalus 60 g, cooked rehmannia 60 g, Ergu 30 g, betel nut slices 4 δ g, Sichuan army 15 g, Yuanming powder 15 g, dried toad 8 g, acute child 10 g, Zhuru 20 g and vermiculite 45 g;
取辅助原料:  Take auxiliary materials:
麸皮 4 5 g , 细糠 4 5 g , 酵母 1 5 g , 红糖 3 5 g , 黄豆粉 3 '5 g , 碳酸 钙 1 0 g ; 45 g of bran, 45 g of fine bran, 15 g of yeast, 35 g of brown sugar, 3'5 g of soy flour, 10 g of calcium carbonate ;
取菌草酸酶为参考例 3 - A制成的纤维素 0 . 2 g 和參考例 2 制成的真菌蛋 白酶 0 . 1 g ;  Take bacterial oxalase as cellulose 0.2 g made in Reference Example 3-A and fungal protease 0.1 g made in Reference Example 2;
用于接种的担子菌原浆和 / 或海藻原浆的混合物依次为: 香菇原浆 0 . 2 g, 海带原浆 0 · 1 g , 炅芝原浆 0, , 1 g ? . The mixture of basidiomycete puree and / or seaweed puree used for inoculation is: 0.2 g of mushroom puree, kelp puree 0.1 g, ganoderma puree 0,, 1 g ?.
重复实施例 1 的方法, 制成合永量 6 %的成品 1 1 8 0 g。  The method of Example 1 was repeated to produce a finished product of 6% of the total volume of 11.8 g.
该产品主治肝癌、 胰头癌。 实施例 5  This product treats liver cancer and pancreatic head cancer. Example 5
取担子菌与海藻类: 银耳 1 0 0 g ·, 香菇 1 5 g , 发菜 5 0 g ;  Take basidiomycetes and seaweeds: Tremella 100 g ·, shiitake mushrooms 15 g, lettuce 50 g;
取中草药: 玄参 3 0 g , 麦冬 3 0 g , 生地黄 3 0 g , 赤芍 2 0 g , .丹皮 2 Take Chinese herbal medicine: 30 g of black ginseng, 30 g of Ophiopogon, 30 g of Rehmannia glutinosa, 20 g of red peony,.
0 g , 黄芪 3 0 g , 山药 3 0 g , 祧仁 2 0 g , 红花 1 5 g , 柒胡 5 g 和海参 70 g, astragalus 30 g, yam 30 g, coix seed 20 g, safflower 15 g, hoehu 5 g and sea cucumber 7
5 g ; 5 g;
取辅助原料: 麸皮 8 0 g , 细糠 7 0 g , 地瓜粉 8 0 g , 酵母 1 5 g , 蔗糖 2 0 g , 碳酸钙 1 0 g ; Take auxiliary materials: bran 8 0 g, polishings 7 0 g, sweet potato powder 8 0 g, yeast 1 5 g, sucrose 20 g, calcium carbonate 10 g;
取菌草酸酶为参考例 3 - A制 的 维 酶 0 . 1 8 g 和参考例 4 制成的果 胶酶 0 . 0 1 g ;  Take bacillary oxidase as reference enzyme 0.18 g made in Reference Example 3-A and pectinase 0.01 g made in Reference Example 4;
用于接种的担子菌原浆和 / 或海藻原浆的混合物依次为: 香菇原浆 0 . 1 6 g , 海带原浆 0 . 0 8 g , 炅芝原浆 0 . 0 9 g。  The mixture of basidiomycete puree and / or seaweed puree used for inoculation is: lenticular puree 0.16 g, kelp puree 0. 8 g, and ganoderma puree 0. 9 g.
重复实施例 1 的方法, 制成合水量 6 %的成品 7 1 5 g。  The method of Example 1 was repeated to produce a finished product 715 g with a water content of 6%.
该产品可用于治疗糖尿病中、 晚期。 . , 实施例 6  This product can be used to treat middle and advanced stages of diabetes. . Example 6
取担子菌与海藻类: 香菇 3 0 g , 猪苓 2 0 g , 茯苓 5 0 g , 海带 5 0 g ; 取中草药: 黄芪 2 0 g , 党参 2 0 g , 防已 2 0 g , 白术 2 0 g , 生首乌 3 Take Basidiomycetes and seaweed: 30 g of Lentinus edodes, 20 g of Poria, 50 g of Poria, 50 g of kelp; Chinese herbal medicine: 20 g of Astragalus, 20 g of Codonopsis, 20 g of Fangshen, 2 0 of Atractylodes g, Shouwu 3
0 g , 泽泻 4 0 g , 山楂 4 0 g , 茵陈 4 0 g , 水牛角 3 0 g , 淫羊藿 3 0 g 和 大黄 6 g ; 0 g, Alisma 40 g, Hawthorn 40 g, Yin Chen 40 g, Buffalo Horn 30 g, Epimedium 30 g and Rhubarb 6 g;
取辅助原枓: 麸皮 1 0 0 g , 细糠 6 0 g , 地瓜粉 6 0 g , 面包酵母 1 2 g , 红糖 1 2 g , 碳酸钙 1 2 g ;  Take the auxiliary raw mash: 100 g of bran, 60 g of fine bran, 60 g of sweet potato flour, 12 g of baker's yeast, 12 g of brown sugar, and 12 g of calcium carbonate;
取菌草酸酶为参考例 3 - A制成的纤维 f酶 0 . 1 8 g 和参考例 2 制成的真 菌蛋白酶 0 . 0 8 g ; ;  Take the bacterial oxalase as the fiber f enzyme 0.18 g made in Reference Example 3-A and the fungal protease 0.08 g made in Reference Example 2;
用于接种的担子菌原浆和 / 或海藻原浆的混合物依次为: 香菇原浆 0 . 1 5 g , 蘑菇原浆 0 . 0 8 g , 炅芝原浆 0 . 0 9 g。  The mixture of basidiomycete puree and / or seaweed puree used for inoculation is: 0.15 g of mushroom puree, 0.08 g of mushroom puree, and 0.99 g of ganoderma puree.
重复实施例 1 的方法, 制成合水量为 6 %的成品 6 8 5 g。 The method of Example 1 was repeated to obtain a finished product of 6 8 5 g with a hydration content of 6 %.
该产品可以治疗单纯性肥胖 ^« 实施例 7  This product can treat simple obesity ^ «Example 7
取担子菌与海藻类: 香菇 2 0 0 g , 海带 1 0 0 g ; Take basidiomycetes and seaweed: 200 g of shiitake mushrooms, 100 g of kelp ;
取中草药: 何首乌 2 2 0 g , 女贞子 1 0 0 g , 怀山药 1 0 0 g , 桑椹 5 0 g 和杭白菊 4 0 g ;  Chinese herbal medicine: Polygonum multiflorum 220 g, Ligustrum lucidum 100 g, Huai yam 100 g, Mulberry 50 g and Hangbai chrysanthemum 40 g;
取辅助原料: 麸皮 1 2 0 g , 细糠 6 0 g, 酵母 1 2 g , 红糖 2 0 g , 碳酸 钙 1 2 g ; Take auxiliary materials: 120 g of bran, 60 g of fine bran, 12 g of yeast, 20 g of brown sugar, 12 g of calcium carbonate;
取菌草酸酶为参考例 3 - B制^的^维素酶 0 · 2 g 和参考例 1 制成的 α淀 粉酶 0 . 1 g ; Bacterial oxidase was used as reference ^ vitamin E enzyme 2 · 2 g made in Reference Example 3 -B and α amylase 0.1 g made in Reference Example 1;
用于接种的担子菌原浆和 / 或海藻原浆的混合物依次为: 炅芝原浆 0 . 1 6 g , 海带原浆 0 . 0 8 g , 佥针菇原浆 0 . 0 8 g。 重复实施例 1 的方法, 制成合水量 6 %的成品 9 8 8 g。 The mixture of basidiomycete puree and / or seaweed puree used for inoculation is: 0.16 g of raw oyster puree, 0.08 g of kelp raw puree, and 0.08 g of raw mushroom puree. The method of Example 1 was repeated to obtain a finished product of 9 8 8 g with a water content of 6 %.
该产品具有养血、 滋肝、 补贤、 促进头发生长的作用, 用于全秃、 脂秃、 斑 禿、 青壮年白发。 工业实用性  This product has the functions of nourishing blood, nourishing liver, nourishing sage, and promoting hair growth. It is used for baldness, alopecia areata, alopecia areata, and young white hair. Industrial applicability
本发明具有如下特点, 因而可具有广泛的用途:  The invention has the following characteristics, and thus can have a wide range of applications:
1 、 用本发明方法制备的劝能保健药物合有菌体蛋白, 海藻单细胞可溶性蛋 白, 中草药有效成分以及微量营.养元素.等成^组成, 它因有 ^胞活性强的小分子 蛋白和多肽物质, 能穿透大脑屏障和细胞膜, 到达发病区域, 杀灭疾病因子和病 毒, 经临床证明, 本药物对治疗老年衰老病症等疾病有显著疗敗, 并能有延缓衰 老劝效。 本发明的劝能.保.健药物与类似配方坷釆用其他炮制方法制成的药物相比 具有疗效好、 作用快的明显劝效。  1. The persuasive health care medicine prepared by the method of the present invention is combined with bacterial protein, seaweed single-cell soluble protein, active ingredients of Chinese herbal medicines, and trace nutrients. Nutrient elements. It is composed of small molecule proteins with strong cell activity. And peptide substances, can penetrate the brain barrier and cell membranes, reach diseased areas, and kill disease factors and viruses. Clinically proven, this drug has a significant effect on the treatment of diseases such as aging and aging, and can delay the aging effect. The persuasion, health-preserving medicine of the present invention has the obvious persuasion effect that the curative effect is good and the effect is fast compared with the similar formula and the medicine made by other processing methods.
2 、 该保健药物综合治疗劝能好, 便于与其他药物配伍, 增强对病疾疗敗。  2. The comprehensive treatment of this health-care medicine is good, it is easy to be compatible with other medicines, and it can strengthen the treatment of disease and disease.
3 、 本发明方法制备的保健药物中测得各种组分的合量 (重量百分数) 为: 蛋白质 10.046¾ 脂肪 2.843*  3. The total amount (weight percentage) of various components measured in the health medicine prepared by the method of the present invention is: protein 10.046¾ fat 2.843 *
皋菌多糖 40·5¾ 维生素 4.04*  Pseudomonas polysaccharide 40 · 5¾ Vitamin 4.04 *
游离氨基酸 8.8*  Free Amino Acids 8.8 *
其中(单位: mg/100g):  Of which (Unit: mg / 100g):
异亮氨酸 0.342 亮氨酸 0. 6  Isoleucine 0.342 Leucine 0.6
赖氨酸 0.57 苯丙氨酸 0. 345 苏氨酸 0.42 缀數酸 0. 996 酪氨酸 0.27 丙氨酸 0. 594 精氨酸 0.288 天门氨酸 0. 75 丝氨酸 1.492 胱氨酸 0. 042 甘氨酸 0.324 色氨酸 0. 082 谷氨酸 0.81 缉氨酸 0. 408 蛋氨酸 0.054 脯氨酸 0. 423 徼量元素 (mg/lOOg)  Lysine 0.57 phenylalanine 0.345 threonine 0.42 succinic acid 0.996 tyrosine 0.27 alanine 0.594 arginine 0.288 aspartic acid 0.75 serine 1.492 cystine 0.042 glycine 0.324 tryptophan 0.082 glutamic acid 0.81 glutamic acid 0.408 methionine 0.054 proline 0.423 element (mg / lOOg)
钾 289 硪 24  Potassium 289 硪 24
钠 2.3 镁 26  Sodium 2.3 Magnesium 26
钙 1177 磷 110  Calcium 1177 Phosphorus 110
铁 150 维生素 (mg/100g) Iron 150 Vitamin (mg / 100g)
胡萝卜素 0.1 核黄素 0.13  Carotene 0.1 riboflavin 0.13
琉胺素 0.03 烟酸 0.9  Leucine 0.03 niacin 0.9
钴胺素 • 0.81 抗坏血酸 0.19  Cobalamin • 0.81 Ascorbic acid 0.19
氨基酸锗 , Oppm/ipog, .■ .  Amino acid germanium, Oppm / ipog,. ■.
氨基酸硒 250ppm/100g  Amino acid selenium 250ppm / 100g
以及少量的多酚氡化酶, 甘露聚糖, 植酸, 1 , 3 - B -葡荀糖苷酶, 植物辍, 发酵素, 岩藻多糖等。 生物发酵物中合有的镉、 汞、 铅等重佥属的合量在允许的 范围内。 As well as a small amount of polyphenol hydratase, mannan, phytic acid, 1, 3-B-glucosaminidase, plant extracts, fermentin, fucoidan, etc. The total amount of heavy genus such as cadmium, mercury, and lead in biological fermentation products is within the allowable range.
4、 本发明的生物发酵物制成的粉剂給 白鼠灌胃给药无法测出 LD5。。 急性 毒性试验做最大耐受量测定, 试验方法参见《中药新药毒理学研究指南》编写組 编写的 "中药新药与临床药理" 1993; 4(3) :13 和中华人民共和国卫生部制定发 布的 "新药审批办法《有关中药部分的修订和补充规定》 " 1992:18。 以实施例 1 的产品为例, 实验用小白鼠 20只; 雌 ϋ备半, 本发明的生物发酵物最高浓度 (28%), 最大容积 0.4ml/10gBW。 每 4小时一次, 连续 3次, 观察 7 天末见毒性反应 和死亡。 计算出本发明的生物发酵物小鼠灌胃給药的 LD5。大于 33.6g/kg, 相当于 推荐临床用量的 917倍。' ' 4, the powders made according to the invention fermentation gavage to rats can not be measured LD 5. . Acute toxicity test is used to determine the maximum tolerated amount. For the test method, please refer to "New Chinese Medicine and Clinical Pharmacology" prepared by the Compilation Group of "Guidelines for the Study of Toxicology of New Chinese Medicine"1993; 4 (3): 13 Measures for the Examination and Approval of New Drugs, "Revisions and Supplementary Provisions on Chinese Medicine" 1992: 18. Taking the product of Example 1 as an example, 20 mice were used for experiments; the females were half prepared, and the highest concentration (28%) of the biological fermentation product of the present invention was 0.4ml / 10gBW. Once every 4 hours, 3 times in a row. Toxicity and death were observed at the end of 7 days. LD 5 was calculated by intragastric administration of the biologically fermented mice of the present invention. More than 33.6g / kg, equivalent to 917 times the recommended clinical dosage. ''
5 、 对因脏腑虚 , 阴阳 调引起的各类; It性病、 老年病共 6 2 例临床应用 实施例 2 产品, 按《中医内科病症诊疗规范》 ^第五版中医大专院校内科教材的 诊断标准, 表明: 对心阳不振 (共 2 1 例) 的总有效率为 9 5 %; 对心脾两虛 ( 共 2 0 例) 的总有效率为 9 0 %; 对心肺双亏 (共 1 1 例) 的总有效率为 9 0 ; 对命门火衰 (共 1 0 例) 的总有效率为 9 2 %。  5. For all kinds of diseases caused by visceral deficiency and yin-yang tone; It has 62 cases of sexually transmitted diseases and senile diseases. It is clinically applied in Example 2. The products are diagnosed according to the "Specifications for the Diagnosis and Treatment of Traditional Chinese Medical Diseases". The standard indicates that: the total effective rate for heart-yang deficiency (total 21 cases) is 95%; the total effective rate for heart-spleen deficiency (total 20 cases) is 90%; 1 case) with a total effective rate of 90; the total effective rate with respect to life-gate fire decay (a total of 10 cases) was 92%.
6 、 本发明的制备工艺简单易行, 设备筒单, 原枓易得, 成本低廉, 便于推 广应用。  6. The preparation process of the present invention is simple and easy, the equipment is simple, the original tin is easy to obtain, the cost is low, and it is convenient for popularization and application.

Claims

1 、 一种生物发酵物, 其中合有按主原料总重量计 32-48*的担子菌的子实体 和海藻类, 以及 52_6 的中草 ^为主原歼, 声草酸酶, 以及以产酶促进剂、 氮源、 碳源、 营养添加剂为辅助原科的发酵产物, 其中: 1 A fermentation product, which has, engaged on the total weight of the main raw material 32-48 * basidiomycetes fruit bodies and seaweed, and the grass _ 52 ^ 6 J mainly original sound oxalate enzymes, as well as Enzyme-promoting agents, nitrogen sources, carbon sources, and nutritional supplements are the fermentation products of the original family, of which:
所述的担子菌与海藻类的重量比为 2: 0.5-1.5;  The weight ratio of basidiomycete to seaweed is 2: 0.5-1.5;
所述的担子菌选自香菇、 佥针兹、 茯苓、 猪苓、 炅芝、 猴头菇、 蘑菇、 银耳 中的一种或数种;  The basidiomycete is selected from one or more kinds of lentinus, edulis, Poria, Hog, Poria, Ganoderma lucidum, Hericium erinaceus, mushroom, Tremella;
所述的海藻类逸自海带、.紫菜、 海 、 .发茱中的一种或两种;  The seaweed escapes from one or two of kelp, seaweed, sea, and dogwood;
所述的菌草酸酶选自 淀粉酶, 纤维酶, 果胶酶, 真菌蛋白酶中的一种或多 种, 其添加量为原料总重量的 0.01-0.03%;  The bacterial oxalase is selected from one or more of amylase, cellulase, pectinase, and fungal protease, and the added amount is 0.01-0.03% of the total weight of the raw material;
所述的产酶促进剂选自酵母 *或玉米浆或其混合物;  The enzyme-promoting agent is selected from yeast * or corn slurry or a mixture thereof;
所述的氮源和碳源选自蛋白胨、 麦皮、 细糠、 地瓜粉、 玉米粉、 麸皮、 米糠、 马钤薯粉、 土茯苓粉、 豆饼粉、 花生饼粉、 菜籽饼粉、 黑芝麻粉、 红糖、 白糖中 的一种或多种;  The nitrogen source and carbon source are selected from the group consisting of peptone, wheat husk, fine bran, sweet potato flour, corn flour, bran, rice bran, mashed potato flour, tulle powder, bean cake powder, peanut cake powder, rapeseed cake powder, One or more of black sesame powder, brown sugar and white sugar;
所述的营养添加剂是合有磷、 钙、 f、 镆、 硒、 锌的无机盐和矿物质; 上述主原科与产酶促进剂、 氮源、 碳源、 营养添加剂的重量比为 100: 0.02 -0.1: 0.18-0.22: 4.6-5.4: 0.14-0.16。  The nutritional additives are inorganic salts and minerals combined with phosphorus, calcium, f, thallium, selenium, and zinc; the weight ratio of the main original family and the enzyme-promoting agent, nitrogen source, carbon source, and nutritional additive is 100: 0.02 -0.1: 0.18-0.22: 4.6-5.4: 0.14-0.16.
2、 如杈利要求 1 所述的生物发酵物, 其特征在于:  2. The biological fermentation product according to claim 1, characterized in that:
所述的担子菌与海藻类具有如下的重量百分数:  The basidiomycetes and seaweeds have the following weight percentages:
香菇 7-8%, 佥针菇 18-19*, 茯苓 1-2¾, 炅芝 2-3%, 海带 14-16%;  7-8% shiitake mushrooms, 18-19 * mushrooms, Poria cocos 1-2¾, Ganoderma 2-3%, kelp 14-16%;
所述的中草药具有如下重量百分数的赶分:.  The Chinese herbal medicine has the following weight percentages:
柏子仁 7-8%, 蛇床子 3-4%, 菟丝子 3-4 覆盆子 3-4¾ί, 石斛 2-3 巴戟天 1 -2%, 续断 4-5 乌药 0.5-1 , 菖蒲 1-1.5 泽泻 0.5-1 山药 1-2*, 人参 1-2 熟地黄 2-3*, 桑寄生 0.5-1%, 山茱萸 1-1.5¾, 五咮子 3-5¾1, 钟乳石 1-2%, 肉苁蓉 2-3*和牛藤 0.7-3 ;  Boziren 7-8%, Shezizi 3-4%, Cuscuta 3-4 Raspberry 3-4¾ί, Dendrobium 2-3 Morinda officinalis 1-2%, Continuity off 4-5 Black medicine 0.5-1, Calamus 1- 1.5 Alisma 0.5-1 yam 1-2 *, ginseng 1-2 cooked rehmannia 2-3 *, mulberry parasitic 0.5-1%, dogwood 1-1.5¾, five gardenias 3-5¾1, stalactites 1-2%, cistanche 2-3 * Wagyu 0.7-3;
所述的辅助原料为具有如下童量百分数^组分:  The auxiliary raw material is a component having the following percentage of child weight:
蛋白胨 0.01-0.02¾, 红糖 0.2-0.3 石奢粉 1%, KC1 0.4-0.5%, MgSO40.4-0. 5%, H2PO40.4-0.5%, ( HJ2S040.3-0.35%0 Peptone 0.01-0.02¾, brown sugar 0.2-0.3 stone luxury powder 1%, KC1 0.4-0.5%, MgSO 4 0.4-0. 5%, H 2 PO 4 0.4-0.5%, (HJ 2 S0 4 0.3-0.35% 0
所述的菌草酸酶为所述的纤维素酶。  The bacterial oxalase is the cellulase.
3 、 如杈利要求 1 所述的生物发酵^, ^特征在于:  3. The biological fermentation according to claim 1, which is characterized by:
所述的担子菌与海藻类具有如下的重量百分数: 香菇 7-8*, 佥针菇 4-6 土茯苓 1-2 炅芝 2-3 海带 7-8%; The basidiomycetes and seaweeds have the following weight percentages: Shiitake Mushroom 7-8 *, Enoki Mushroom 4-6, Earth Poria 1-2, Ganoderma 2-3, Kelp 7-8%;
所述的中草药具有如下重量百分数的组分:  The Chinese herbal medicine has the following weight percentage components:
柏子仁 4-5%, 蛇床子 4·4·5%, 菟丝子 4-4.5*, 覆盆子 4-4.5%, 石斛 1-1.5%, 巴戟天 1-1.5¾ί, 杜仲 1-1.5 天门冬 1-1.5¾!, 志远 (去心)1-1.5*, 益智仁 0.2-0 .5%, 续断 0.5-0.7*, 乌药 0.5-0. 'ή, 0.7-1%, 泽泻 0.7-1 山药 0.8-1* , 人参 0.8-1 熟地黄 0.5-0.8 山茱萸 0.6-1%, 五味子 2-3*, 钟乳石(炼) 1-1.2%, 肉苁蓉 2-3<fe; Bozi 4-5%, Cnidium 4.4 4.5%, dodder 4 - 45 *, raspberry 4-4.5%, 1-1.5% Dendrobium, Morinda 1-1.5¾ί, gutta 1-1.5 Tianmen Winter 1-1.5¾ !, Zhiyuan (Go to heart) 1-1.5 *, Zhiren kernel 0.2-0.5%, On-off 0.5-0.7 *, Black medicine 0.5-0. 'Price, 0.7-1%, Ze Xie 0.7-1 yam 0.8-1 *, ginseng 0.8-1 cooked rehmannia 0.5-0.8 dogwood 0.6-1%, Schisandra 2-3 *, stalactite (refined) 1-1.2%, cistanche 2-3 <fe;
所述的辅助原料为具有如下重量百分数的组分:  The auxiliary raw materials are components having the following weight percentages:
麸皮 7-8%, 细糠 7-8%, 地 粉 酵母 i-1.2%, 蔗糖 1-1.2%, 碳酸钙 1 -1.2%。  Bran 7-8%, fine bran 7-8%, ground flour yeast i-1.2%, sucrose 1-1.2%, calcium carbonate 1-1.2%.
4、 如杈利要求 1 所述的生物发酵物, 其特征在于:  4. The biological fermentation product according to claim 1, characterized in that:
所述的担子菌与海藻'类具有如下的重量百分数:  The basidiomycetes and seaweeds have the following weight percentages:
土茯苓 7-8%, 炅芝 7-8%, 带 7-8  Poria cocos 7-8%, Ganoderma lucidum 7-8%, with 7-8
所述的中草药具有如下重量百分数的组分;  The Chinese herbal medicine has the following weight percentage components;
何首乌(制) 5-6%、 怀牛膝 3-4 菟丝子 3-4%, 女贞子 3-4%, 生杜仲 4-5%, 莶草 5-6 桑叶 2-3%, 银花 3-4 黑桑椹 3-4%, 枸杞子 0.3-0. 4%, 菊花 5 -6%, 地黄 3-4 山萸肉 3-4%, 丹皮 3-4 泽泻 0.3-0.4 山药 3-4¾;  Polygonum multiflorum (manufactured) 5-6%, pregnant with Achyranthes bidentata 3-4, Cuscuta 3-4%, Ligustrum lucidum 3-4%, Eucommia ulmoides Oliv. 4-5%, Corydalis 5-6 Mulberry leaves 2-3%, Silver flower 3-4 black mulberry 3-4%, Chinese wolfberry 0.3-0. 4%, chrysanthemum 5 -6%, radix rehmanniae 3-4 mangosteen meat 3-4%, tank 3-4 Alisma 0.3-0.4 yam 3- 4¾;
所述的辅助原料为具有如下重量百分数的组分:  The auxiliary raw materials are components having the following weight percentages:
麸皮 7-8 细糠 7-8%, 酵母 1-1.2 蔗糖 1-1.2 碳酸钙 1-1.2%;  Bran 7-8 fine bran 7-8%, yeast 1-1.2 sucrose 1-1.2 calcium carbonate 1-1.2%;
所述的菌草酸酶为 0.02*的纤维素酶和 0.01%的果胶酶。  The bacterial oxalase is 0.02 * cellulase and 0.01% pectinase.
5、 如扠利要求 1 所述的生物发酵物, 其特征在于:  5. The biological fermentation product according to Forklift claim 1, characterized in that:
所述的担子菌与海藻类具有'如卞的重量百分数:  The basidiomycetes and seaweeds have a weight percentage of Rugao:
香菇 3-4 蘑菇 3-4%, 猴头菇 3-4¾;, 海带 5-6  Shiitake Mushroom 3-4 Mushroom 3-4%, Hericium Mushroom 3-4¾ ;, Kelp 5-6
所述的中草药具有如下重量百分数的组分:  The Chinese herbal medicine has the following weight percentage components:
黄药子 10-20*, 川断' 4-5<¾, 沙苑子 牡蛎 3 -4%, 莪术 3 -4*, 祧仁 3 -4 川楝子 4-5*, 青皮 3-4 蜈蚣 1,2-1.5*, 斑蟊 1.2-1.5<fe, 滑石 3-4 独角莲 3- , 砂仁 2-3 鸡佥内 2-3 党參 2-3*, 黄芪 3-6 熟地黄 3-6%, 二丑 3-6%, 槟榔片 3-6%, 川军 l-2<fe, 元明粉 1-2 干蛤蟆 0·5-1*, 急性子 0.6-1.2%, 竹茹 2-3%和代 赭石 4-5*;  Huangyaozi 10-20 *, Chuanchuan '4-5 <¾, Shayuanzi oysters 3-4%, Curcuma 3-4 *, Coix seed 3-4 Chuanxiongzi 4-5 *, Qingpi 3-4 蜈蚣 1,2 -1.5 *, cantharicus 1.2-1.5 <fe, talc 3-4 unicorn 3-, amomum 2-3 chicken gizzard 2-3 codonopsis 2-3 *, astragalus 3-6 cooked rehmannia 3-6% , Erhu 3-6%, betel nut slices 3-6%, Sichuan army l-2 <fe, Yuanming powder 1-2 dried toad 0 · 5-1 *, acute offspring 0.6-1.2%, Zhuru 2-3% and Substitute 4-5 *;
所述的辅助原料为具有如下重量百分数的組分:  The auxiliary raw materials are components having the following weight percentages:
麸皮 4-5%, 细糠 4-5 酵母 1·.2-1.5%, 红糖 3-4¾, 黄豆粉 3-4%, 碳酸钙 1-1 Bran 4-5%, fine bran 4-5 yeast 1. · 2-1.5%, brown sugar 3-4¾, soy flour 3-4%, calcium carbonate 1-1
.2%; 所述的菌草酸 ϋ为 0.02%的上述纤维素酶和 0.01%的上述果胶酶。 .2%; The fungal oxalate is 0.02% of the above-mentioned cellulase and 0.01% of the above-mentioned pectinase.
6、 如杈利要求 1 .所述的生物发酵物, 其特征在于:  6. The biological fermentation product according to claim 1, characterized in that:
所述的担子菌与海藻类具有如下的重量百分数:  The basidiomycetes and seaweeds have the following weight percentages:
银耳 10-15*, 香菇 1.5-4.5 '发菜 5-8 '  Tremella 10-15 *, Shiitake Mushroom 1.5-4.5 'Hot Vegetables 5-8'
所述的中草药具有如下重量百分数的組分:  The Chinese herbal medicine has the following weight percentage components:
玄参 3-4*, 麦冬 3-4*, 生地黄 3-4 赤芍 1-2 丹皮 1-2*, 黄芪 3-4 山药 3-4%, 祧仁 1-2*, 釭花 1-2 柴胡 0.5-0.6¾;和海参 7-8^  Scrophularia 3-4 *, Ophiopogon 3-4 *, Raw Dihuang 3-4 Chiba 1-2 Danpi 1-2 *, Astragalus 3-4 Yam 3-4%, Coix Seed 1-2 *, Coriander flower 1-2 Bupleurum 0.5-0.6¾; and sea cucumber 7-8 ^
所述的辅助原枓为具有如下重量百分数的组分:  The auxiliary raw material is a component having the following weight percentage:
麸皮 6-8%, 细糠 6-8 地瓜粉 6-8 酵母 1.2-2 総 1.2-2*, 碳酸钙 1-1 Bran 6-8%, fine bran 6-8 sweet potato powder 6-8 yeast 1.2-2 総 1.2-2 *, calcium carbonate 1-1
.2%; .2%;
所述的菌草酸酶为 0.02%的上述纤维素酶和 0.01¾的上述果胶酶。  The bacterial oxalase is 0.02% of the aforementioned cellulase and 0.01¾ of the aforementioned pectinase.
7、 如杈利要求 1 所述的生.物发酵物, 其特征在于:  7. The biological fermentation product according to claim 1, characterized in that:
所述的担子菌与海藻类具有如下的重量百分数:  The basidiomycetes and seaweeds have the following weight percentages:
香菇 2-3%, 猪苓 1-2 茯苓 4-5*, 海带 4-5*;  Shiitake 2-3%, Poria 1-2 Poria 4-5 *, Kelp 4-5 *;
所述的中草药具有如.下重量百分数的组分:  The Chinese herbal medicine has the following weight percentage components:
黄芪 1-2%, 党参 1-2 防已 1-2 0木 1-2*, 生首乌 2- , 泽泻 4-8*, 山楂 2-4%, 茵陈 2-4 水牛角 2-4¾,· 淫羊藿 2-4*和大黄 0.6-1%;  Astragalus 1-2%, Codonopsis 1-2 prevention has 1-2 0 wood 1-2 *, raw Shouwu 2-, Zexie 4-8 *, hawthorn 2-4%, Yin Chen 2-4 buffalo horn 2- 4¾, · Epimedium 2-4 * and rhubarb 0.6-1%;
所述的辅助原枓为具有如下重量百分数的組分:  The auxiliary raw material is a component having the following weight percentage:
麸皮 10-12*, 细糠 5_6¾, 地瓜粉 5-6¾, 面包酵母 1-1.2*, 红糖 1-1.2 碳酸 ^51-1.2%; 10-12 * bran, fine bran 5 _6¾, sweet potato powder 5-6¾, 1-1.2 * baker's yeast, brown sugar ^ 51-1.2 1-1.2% carbonate;
所述的菌草酸酶为 o. im的上.迷纤维素酶 oo.01*的上述真菌蛋白酶。  The bacterial oxalase is the above-mentioned fungal protease of o.im. i. Cellulase oo.01 *.
8 、 如杈利要求 1 所述的生物发酵物, 其特征在于:  8. The biological fermentation product according to claim 1, characterized in that:
所述的担子菌与海藻类具有如下的重量百分数:  The basidiomycetes and seaweeds have the following weight percentages:
香菇 15-20*, 海带  Shiitake 15-20 *, Kelp
所述的中草药具有如下重量百分数的组^:  The Chinese herbal medicine has the following weight percentages:
何首乌 18-22*, 女贞子 9-10 怀山药 9-10*, 桑椹 4-5¾ί和杭白菊 3-4¾;; 所述的辅助原科为具有如下重量百分数的组分:  Polygonum multiflorum 18-22 *, Ligustrum lucidum 9-10 Huai yam 9-10 *, Mulberry 4-5¾ί and Hangbaiju 3-4¾ ;; The auxiliary primary family is a component having the following weight percentages:
麸皮 10-12*, 细糠 5-6%, 酵母 1-1.2*, 红糖 1.5-2.5*, 碳酸钙 1-1.2%; 所述的菌草酸酶为 0.02*的上述纤维素酶和 0.01*的上述淀粉酶。  Bran 10-12 *, fine bran 5-6%, yeast 1-1.2 *, brown sugar 1.5-2.5 *, calcium carbonate 1-1.2%; the bacterial oxalase is 0.02 * of the above-mentioned cellulase and 0.01 * Of the above amylase.
9、 一种生物发酵物的制备方法, 其特征在于包合如下步骤:  9. A method for preparing a biological fermentation product, comprising the following steps:
(1) 取药物主原科, 其中包括重量比为 32 - 48的菌类和海藻类, 和重量比为 52 - 68的中草药, 菌草酸酶; 取产酶促进剂、 氮源、 碳源和营养添加剂作为药物 辅助原科; (1) Take the main drug family, which includes fungi and seaweeds with a weight ratio of 32 to 48, and Chinese herbal medicines with a weight ratio of 52 to 68, bacterial oxalase; obtain enzyme production promoters, nitrogen sources, carbon sources, and Nutritional additives as medicine Auxiliary department
(2) 将上述的菌类和海藻类以及上述中草药分别粉碎成粉末状;  (2) pulverizing the above-mentioned fungi and seaweed and the above-mentioned Chinese herbal medicine into powders;
(3) 将上述中草药粉末用 15*浓度乳酸浸泡 24小时, 后加入上述粉碎后的菌 类和海藻粉末, 混合搅拌.下加入上述药物辅助原料, 充分搅拌得一混合原料, 灭 菌;  (3) immerse the Chinese herbal medicine powder with 15 * concentration of lactic acid for 24 hours, and then add the crushed fungi and seaweed powder, mix and stir; add the above mentioned drug auxiliary raw materials, and stir thoroughly to obtain a mixed raw material to sterilize;
' (4) 将 (3)所述的混合原科和菌草酸酶置于生物反应器中, 在 30- 55eC、 用 乳酸调节 PH值至 4.0-6.5, 通气培养 5-8天, 每天搅拌 1-2次, 并在开始发酵第 24 小时开始, 每 24小时接入为主原枓总重量 1-2*的一种担子菌的原浆和 / 或海藻浆 的混合物, 接种次数为 2 -3次, 得发酵产物; '(4) Put the mixed proteaceae and bacterial oxalase described in (3) in a bioreactor, adjust the pH to 4.0-6.5 with lactic acid at 30-55 e C, and culture for 5-8 days aeration, daily Stir 1-2 times, and start the fermentation on the 24th hour. Every 24 hours, a mixture of a basidiomycete puree and / or seaweed pulp is used. The number of inoculations is 2 -3 times to get fermentation product;
(5) 将上述发酵产物离心弃溏、 吸附脱 、 浓缩、 干燥后制成产品; 其中:  (5) centrifugally discarding the fermentation product, desorbing, concentrating, and drying to produce the product; wherein:
所述的担子菌与海藻类的重量比为 2: 0.5-1.5;  The weight ratio of basidiomycete to seaweed is 2: 0.5-1.5;
所述的担子菌选自香菇、 佥针菇、 茯苓、 猪苓、 炅芝、 猴头菇、 蘑菇、 银耳 中的一种或数种;  The basidiomycete is selected from one or more kinds of Lentinula edodes, Flammulina velutipes, Poria, Hodgkin, Ganoderma lucidum, Hericium erinaceus, mushroom, and Tremella;
所述的海藻类选自海带、 紫菜、 海藻、 发菜中的一种或两种;  The seaweed is selected from one or two of kelp, laver, seaweed, and hairweed;
所述的菌草酸酶选自 α -淀粉酶, 纤维酶, 果胶酶, 真菌蛋白酶中的一种或 多种, 其添加量为原料.总.重量的 0.01-0.0^;  The bacterial oxalase is selected from one or more of α-amylase, cellulase, pectinase, and fungal protease, and the added amount is the raw material. Total weight 0.01-0.0 ^;
所述的产酶促进剂选自酵母裔或玉米浆或其混合;  The enzyme-promoting agent is selected from yeast or corn syrup or a mixture thereof;
所述的氮源和碳源选自蛋白胨、 麦皮、 细糠、 地瓜粉、 玉米粉、 麸皮、 米糠、 马铃薯粉、 土茯苓粉、 豆饼粉、 花生饼粉、 菜籽饼粉、 黑芝麻粉、 红糖、.白糖中 的一种或多种;  The nitrogen source and carbon source are selected from the group consisting of peptone, wheat husks, fine bran, sweet potato flour, corn flour, bran, rice bran, potato flour, tulle powder, bean cake powder, peanut cake powder, rapeseed cake powder, and black sesame seeds. One or more of powder, brown sugar, and white sugar;
所述的营养添加剂是合有磷、 钙、 钾、 镆、 硒、 锌的无机盐和矿物质; 上述主原料与产酶促进剂、 源、 碳源、 营养添加剂的重量比为 100: 0.02 -0.1: 0.18-0.22: 4.6-5.4: 0.14-0.16。  The nutritional additives are inorganic salts and minerals combined with phosphorus, calcium, potassium, thallium, selenium, and zinc; the weight ratio of the main raw material to the enzyme-promoting agent, source, carbon source, and nutritional additive is 100: 0.02- 0.1: 0.18-0.22: 4.6-5.4: 0.14-0.16.
1 0 、 如杈利要求 9 所述的制备方法, 其特征在于:  1 0. The preparation method according to claim 9 is characterized in that:
所述的《-淀粉酶来源于玉米淀粉 2 , 玉米浆 26¾Γ 磷酸氢二钠 37¾, 氟化钙 The "-amylase is derived from corn starch 2, corn slurry 26¾Γ disodium hydrogen phosphate 37¾, calcium fluoride
1%, 氣化钾 0.2 氟化镁 ο·2 麸床^ 红曲 H 猪胰一条的培养产物; 1%, vaporized magnesium, potassium fluoride 0.2 bran bed ο · 2 ^ H Monascus culture product of a porcine pancreas;
所述的真菌蛋白酶来源于玉米淀粉 30*, '玉米浆 5¾, 大豆粉 5%, 酪蛋白 6% , 明胶 5*, 干洒糟 5%, 磷酸二 I 甲 2.4%, 硝酸钠 1 氯化铵 1 琉酸铁 0.01 麸 皮 5%, 细糠 5 炅芝孢子粉 5 红曲 1*的培养产物; ,  The fungal protease is derived from corn starch 30 *, 'corn slurry 5¾, soy flour 5%, casein 6%, gelatin 5 *, dry sprinkler 5%, dimethyl phosphate 2.4%, sodium nitrate 1 ammonium chloride 1 ferric acid 0.01 bran 5%, fine bran 5 ganoderma spore powder 5 red yeast rice 1 * culture product;
所述的纤维素酶来源于食用菌绿色废菌枓 65%, 麸皮 10%, 细糠 10%, 琉酸铵 2. The cellulase is derived from edible fungus green waste fungus 65%, bran 10%, fine bran 10%, ammonium sulphate 2.
5%, 永 250%, 酵母赍 1¾, 吐温 SO 0.05%, 粗红糖 1%, 红曲 1%的固体发酵产物; 或来源于米糠 1 麸皮 0.5 锍酸铵 0.2 磷酸二氬钾 0.1、 碳酸钙 0.1、 葡萄糖 1*在三角瓶中、 30-C, 104特 /分、 培 32_35小时, 得种子一敬发酵产物; 将废菌料 、 麸皮 0.5%、 葡荀糖 1 琉^铵 0.2、 磷酸二氬钾 0.1*在 30· (:、 104 转 /分、 培养 60小时, 得种子二级培养物; 将种子一级、 二级培养物、 蛋白胨 0 .075%, 吐温 80 0.2、 琉酸铵 l.4g/I 磷酸二氢钾 2. Og/ 尿素 O.Sg/L^ 氣化钙 0.3g/ I 琉酸镁 OJg/I 琉酸铁 S.Og/I^ 琉酸锰 l.Sg/ 琉酸锌 l g/ 氣化 钴 2. Og/L, 并以分子量为 2000的聚丙二.醇作,消淮剂所进行的浪体发酵的产物; 所述的果胶酶来源于果胶 4%、 蛋白胨 0.4 锍酸钠 0.05%、 琉酸铁 0.01¾、 琉 酸镁 0.05¾、 氟化钾 0.05%、 磷酸二氢鉀 0.1%、 麸皮 5¾、 细糠 5%、 蔗糖 2 硝酸铵 0.2%、 硝酸钠 0.2*, 并接入合有 2X103个孢子的炅芝孢子悬浮浪, 30'C, 在三角 烧瓶中培养 7 天得到的培养产物, 其中的百分比为重量百分比。 5%, Yong 250%, Yeast 赍 1¾, Tween SO 0.05%, Crude Brown Sugar 1%, Monascus 1% solid fermentation product; Bran derived from rice bran, or a sulfonium, ammonium 0.5 0.2 0.1 dicalcium phosphate, potassium argon, calcium carbonate, 0.1, 1 * glucose in Erlenmeyer flask, 30-C, 10 4 dtex / min, 32 _ culture 35 hours to obtain a seed King Fermentation product; the waste fungus material, bran 0.5%, glucomannan 1 ammonium 0.2, potassium diargon phosphate 0.1 * at 30 · (:, 104 rpm, 60 hours of cultivation, and a seed secondary culture is obtained; seeds are one, two cultures, peptone, 0.075%, Tween 80 0.2, sulfur, ammonium l. 4 g / I potassium dihydrogen phosphate 2. Og / urea O.Sg/L^ gasification calcium 0.3g / I magnesium sulphate OJg / I iron sulphate S.Og / I ^ manganese sulphate l.Sg/ zinc sulphate lg / cobalt gasification 2. Og / L, and using polypropylene glycol with molecular weight 2000, The product of wave fermentation by Huaihuai; the pectinase is derived from 4% of pectin, 0.4% of sodium peptone, 0.05% of sodium plutonate, 0.01¾ of iron sulphate, 0.05¾ of magnesium sulphate, 0.05% of potassium fluoride , Potassium dihydrogen phosphate 0.1%, bran 5¾, fine bran 5%, sucrose 2 ammonium nitrate 0.2%, sodium nitrate 0.2 *, and connected with 2X10 3 spores of Ganoderma spore suspension wave, 30'C, at The culture product obtained after 7 days of cultivation in an Erlenmeyer flask, where the percentage is The percentage amount.
1 1 、 如杈利要求 1 0 所述的制备方法, 其特征在于:  1 1. The preparation method according to claim 10, characterized in that:
所述的担子菌与海藻类具有如下的重量百分数:  The basidiomycetes and seaweeds have the following weight percentages:
香菇 7-8¾, 金针菇 18-19¾, 茯苓 1-2¾, 炅芝 2-3¾, 海带 14-16¾;  Shiitake Mushroom 7-8¾, Flammulina Mushroom 18-19¾, Poria 1-2¾, Poria 2-3¾, Kelp 14-16¾;
所述的中草药具有如下重量百分数的组分:  The Chinese herbal medicine has the following weight percentage components:
柏子仁 7-8%, 蛇床子 3_4¾, 菟丝子 3- : 覆盆子 3-4%, 石斛 2-3¾, 巴戟天 1 -2%, 续断 4-5%, 乌药 0.5-1 菖蒲 1-1.5¾, 泽泻 0.5-1 山药 1-2%, 人参 1-2¾, 熟地黄 2-3%, 桑寄生 0.5-1*, 山茱萸 1-1.5 五咮子 3-5¾, 钟乳石 1-2 肉苁蓉 2-3*和牛藤 0.7-1 Boziren 7-8%, Snakebed 3 _ 4 ¾, Cuscuta 3- : Raspberry 3-4%, Dendrobium 2-3¾, Morinda officinalis 1-2¾, Continuity off 4-5%, Black medicine 0.5-1 Acorus 1-1.5¾, Alisma 0.5-1 yam 1-2%, Panax ginseng 1-2¾, Rehmannia glutinosa 2-3%, Morus alba 0.5-1 *, Fructus Corni 1-1.5, Fructus Corni 3-5¾, Stalactite 1- 2 Cistanche 2-3 * Wagyu 0.7-1
所述的辅助原料为具有如下重量百分数的 分:  The auxiliary raw materials have the following weight percentages:
蛋白胨 0.01-0.02%, 红糖 0.2-0.3%, 石裔粉 1*, KC1 0.4-0.5%, MgSO40.4-0. 5%, KH2PO40.4-0.5%, ( H4)2SO40.3-0.35%; Peptone 0.01-0.02%, brown sugar 0.2-0.3%, stone powder 1 *, KC1 0.4-0.5%, MgSO 4 0.4-0. 5%, KH 2 PO 4 0.4-0.5%, (H 4 ) 2 SO 4 0.3 -0.35%;
所述的菌草酸酶为所述制成的纤维素酶;  The bacterial oxalase is the prepared cellulase;
所述的用于接种的担子菌原浆和 / 或海藻浆的混合物依次为: 佥针菇原浆, 蘑菇原浆, 重量比为 2:1的炅芝和海带原浆。  The mixture of basidiomycete puree and / or seaweed puree used for inoculation is: Enoki mushroom puree, mushroom puree, Ganoderma lucidum and kelp puree with a weight ratio of 2: 1.
1 2、 如杈利要求 1 0 所述的制备方法, 其特征在于:  12. The preparation method according to claim 1, which is characterized in that:
所述的担子菌与海藻类具有如下的重量百分数:  The basidiomycetes and seaweeds have the following weight percentages:
香菇 7-8 佥针菇 4-6¾, 土茯苓 1-2%, 炅芝 2-3 海带 7- ;  Shiitake 7-8 Shiitake Mushroom 4-6¾, Poria cocos 1-2%, Ganoderma 2-3 Kelp 7-;
所述的中草药具有如下重量百^数的组分:  The Chinese herbal medicine has the following components by weight:
柏子仁 4-5%, 蛇床子 4-4.5¾, 菟丝子 4-4.5¾, 覆盆子 4-4.5¾, 石斛 1-1.5 巴戟天 1-1.5¾, 杜仲 1-1.5*, 天门冬 1-1.5*, 志远(去心)1-1.5 益智仁 0.2-0 .5%, 续断 0.5-0, 7 6, 10.5-0.7%, 菖蒲 0·7-1¾, 泽泻 0.7-1%, 山药 0.8-1%, 人參 0. 8-1*, 熟地黄 0. 5-0. 8¾, 山茱萸 0· 6-1¾:, 五咮子 2-3¾ί, 钟乳石(炼) 1-1. 2*, 肉苁蓉 2-3%; Bozi Ren 4-5%, Snake Bed 4-4.5¾, Cuscuta 4-4.5¾, Raspberry 4-4.5¾, Dendrobium 1-1.5 Morinda officinalis 1-1.5¾, Eucommia 1-1.5 *, Asparagus 1-1.5 *, Zhiyuan (Go to Heart) 1-1.5 Nootropic kernel 0.2-0.5%, On-off 0.5-0, 7 6, 10.5-0.7%, Acorus 0 · 7-1¾, Alisma 0.7-1%, Yam 0.8-1%, Ginseng 0. 8-1 *, Rehmannia glutinosa 0. 5-0. 8 ¾, Dogwood 0. 6-1¾ :, Five Gardenia 2-3¾, Stalactite (refining) 1-1. 2 *, Cistanche 2-3% ;
所述的辅助原料为具有如下兪量百分数 组分:  The auxiliary raw material is a component having the following weight percentage:
麸皮 7-8%, 细糠 7-8%, 地瓜粉 4-4. 2 酵母 1-1. 2%, 蔗糖 1-1. 2 碳酸钙 1 -1. 2%;  Bran 7-8%, fine bran 7-8%, sweet potato powder 4-4. 2 yeast 1-1.2%, sucrose 1-1.2 calcium carbonate 1-1.2%;
所述的菌草酸酶为所述的纤维素酶;  The bacterial oxalase is the cellulase;
所述的用于接种的担子菌 ϋ和 / ¾海¾浆^混合物依 ^为: 佥针菇原浆, 蘑菇原浆, 重量比为 2: 1的炅芝和海带原浆。  The Basidiomycetes ϋ and / ¾ 海 ¾¾ for the inoculation are in the following mixture: enoki mushroom puree, mushroom puree, edible oyster and kelp puree with a weight ratio of 2: 1.
1 3、 如扠利要求 1 0 所述的制备方法, 其特征在于:  1 3. The preparation method according to the fork profit requirement 10, characterized in that:
所述的担子菌与海'藻'类具有如下的重量百分数:  The basidiomycetes and sea 'algae' have the following weight percentages:
土茯苓 7- , 炅^ 7-8%, 海带 7-8¾; ; , Soil Poria 7-, 炅 7-8%, Kelp 7-8¾ ;; ,
所述的中草药具有如下重量百分数的组分;  The Chinese herbal medicine has the following weight percentage components;
何首乌(制) 5-6 怀牛膝 3-4 菟丝子 3-4 女贞子 3-4%, 生杜仲 4-5*, 莶草 5-6¾, 桑叶 2- 3*, 银花 3-4 ¾, 黑桑椹 3- , 枸杞子 0. 3- 0. 4%, 菊花 5 -6%, 地黄 3-4 山萸肉 3-4 丹皮 3- 泽泻 0. 3- 0. 4%, 山药 3-4%;  Polygonum multiflorum (manufactured) 5-6 pregnant with achyranthes 3-4, Cuscuta 3-4, Ligustrum 3-4%, Eucommia ulmoides 4-5 *, Yarrow 5-6¾, mulberry leaf 2 3 *, silver flower 3-4 ¾, black mulberry 3-, wolfberry 0.3-0.4%, chrysanthemum 5-6%, Dihuang 3-4 mandrill meat 3-4 rambutan 3-Zixie 0.3-0.4%, yam 3-4%;
所述的辅助原料为具有如下童量百分数^组分:  The auxiliary raw material is a component having the following percentage of child weight:
麸皮 7- 8*, 细糠 7-8¾, 酵母 1-1. 2¾, 蔗糖 1-1. 2*, 碳酸钙 1-1. 2%;  Bran 7-8 *, fine bran 7-8¾, yeast 1-1. 2¾, sucrose 1-1. 2 *, calcium carbonate 1-1. 2%;
所述的菌草酸酶为 0. 02%所述的纤维素酶和 0. 01*所述的果胶酶;  The bacterial oxalase is 0.02% of the cellulase and 0.011 of the pectinase;
所述的用于接种的担子菌原浆和 / 或海藻浆的混合物依次为: 香菇原浆, 蘑 菇原浆, 海带原浆。 ' '  The mixture of basidiomycete puree and / or seaweed puree used for inoculation is: shiitake mushroom puree, mushroom puree, kelp puree. ''
1 4、 如杈利要求 1 0 所述的制备方法, 其特征在于:  14. The preparation method according to claim 1, which is characterized in that:
所述的担子菌与海藻类具有如下的重量百分数:  The basidiomycetes and seaweeds have the following weight percentages:
香菇 3-4 蘑菇 3-4 , 猴头菇 3-4 海带 5-6*;  Shiitake 3-4 Mushroom 3-4, Hericium 3-4 kelp 5-6 *;
所述的中草药具有如下重 *百分数的组分;  The Chinese herbal medicine has the following components:
黄药子 10-20S?, 川断 4-5*, 沙苑子 4-5*, '牡蛎 3-4%, 莪术 3-4%, 挑仁 3-4%, 川楝子 4-5 青皮 3- 蜈蚣 1.2-1.5*, 斑蟊 1.2-1.5%, 滑石 3- 独角莲 3- , 砂仁 2-3*, 鸡金内 2-3<fe, 党参 2-3*, 黄芪 3-6%, 熟地黄 3-6¾;, 二丑 3-6 槟榔片 3-6%, 川军 1-2*, 元明粉 1-2 干蛤蟆 0. 5-1*, 急性子 0. 6-1. 2 竹茹 2-3*和代 赭石 4-5^  Huangyaozi 10-20S ?, Chuandi 4-5 *, Shayuanzi 4-5 *, 'Oyster 3-4%, Curcuma 3-4%, Pick kernel 3-4%, Chuanxiongzi 4-5 Qingpi 3- 蜈蚣1.2-1.5 *, cantharidium 1.2-1.5%, talc 3- unicorn lotus 3-, amomum 2-3 *, chicken gold 2-3 <fe, codonopsis 2-3 *, astragalus 3-6%, mature land Huang 3-6¾ ;, Er Chou 3-6 Areca Nut Slice 3-6%, Sichuan Army 1-2 *, Yuanming Powder 1-2 Dried Toad 0. 5-1 *, Acute 0. 6-1. 2 Zhuru 2 -3 * 和 代赭石 4-5 ^
所述的辅助原料为具有如下重量百分数的组分:  The auxiliary raw materials are components having the following weight percentages:
麸皮 4-5 细糠 4-5%, 酵母 1. 2-1. 5 红糖 3-4 黄豆粉 3-4 碳酸钙 1-1 所述的菌草酸畴为 0. 02*的所^纤维素酶和 0. 01*的所述果胶酶; Bran 4-5 Fine bran 4-5%, Yeast 1. 2-1. 5 Brown sugar 3-4 Soy flour 3-4 Calcium carbonate 1-1 The bacterial oxalate domain is 0.02 * of the ^ cellulase and 0.01 * of the pectinase;
所述的用于接 ^担子 f 、^ / .或海,藻 的混合物依次为: 瞀菇原浆, 海 带原浆, 炅芝原浆。 '  The mixture used to receive the bascule f, ^ /. Or the sea and algae in this order are: oyster mushroom puree, kelp puree, and oyster puree. '
1 5 、 如杈利要求 1 0 所述的制备方法, 其特征在于:  15. The preparation method according to claim 10 is characterized by:
所述的担子菌与海藻类具有如下的重量百分数:  The basidiomycetes and seaweeds have the following weight percentages:
银耳 10-15*, 瞀菇 1. 5-4. 5*, 发菜 5-8%;  Tremella 10-15 *, oyster mushroom 1. 5-4. 5 *, lettuce 5-8%;
所述的中草药具有如下重量言分数的组夯:  The Chinese herbal medicine has the following groups of weight fractions:
玄参 3-4%, 麦冬 3-4%, 生地黄 3-4 赤芍 1-2 丹皮 1-2%, 黄芪 3-4S;, 山药 3-4%, 祧仁 1-2 红花 1-2*, 柴胡 0. 5-0. 6%和海参 7- 8  Scrophularia 3-4%, Ophiopogon 3-4%, Raw Rehmannia 3-4 Chiba 1-2 Red Bark 1-2%, Astragalus 3-4S ;, Yam 3-4%, Coix Seed 1-2 Safflower 1-2 *, Bupleurum 0. 5-0. 6% and sea cucumber 7- 8
所述的辅助原枓为具有如下重量百分数的组分:  The auxiliary raw material is a component having the following weight percentage:
麸皮 6-8 细糠 6- 8%, 地 '粉 6-8 ·酵每 1. 2-2%, 蔗糖 1. 2-2 碳酸钙 1-1 Bran 6-8 Fine bran 6-8%, Ground powder 6-8Ferment per 1.2-2%, Sucrose 1.2-2 Calcium carbonate 1-1
. 2%; . 2%;
所述的菌草酸酶为 0. 02%的所述纤维素酶和 0. 01*的所述果胶酶;  The bacterial oxalase is 0.02% of the cellulase and 0.01 * of the pectinase;
所述的用于接种的'担子菌原浆和 / 或海藻浆的混合物依次为: 香菇原浆, 海 带原浆, 炅芝原浆。 , ,  The mixture of the basidiomycete puree and / or seaweed puree used for inoculation is: shiitake mushroom puree, kelp puree, and ganoderma puree. ,,
1 6 、 如杈利要求 1 0 所述的制备方法, '其特征在于:  16. The preparation method according to claim 10, characterized in that:
所述的担子菌与海藻类具有如下的重量百分数:  The basidiomycetes and seaweeds have the following weight percentages:
香菇 2-3 , 猪苓 1-2%, 茯苓 4-5 海带 4-5  Shiitake 2-3, Poria 1-2%, Poria 4-5 Kelp 4-5
所述的中草药具有如下重量百分数的组分:  The Chinese herbal medicine has the following weight percentage components:
黄芪 1-2*, 党参 1-2*, 防已 1:2%, 白术 1二2*, 生首乌 2-4 泽泻 4- 8%, 山楂 2-4%, 茵陈 2- 水牛角 2-4%, 淫羊着 2-4*和大黄 0. 6-1¾;; Astragalus 1-2 *, Codonopsis 1-2 *, Fangshen 1 : 2%, Atractylodes 1-2 *, Shengshouwu 2-4 Alisma 4-8%, Hawthorn 2-4%, Yinchen 2-buffalo horn 2-4%, Epimedium 2-4 * and Rhubarb 0.6-1 / 2;
所述的辅助原枓为具有如下重量百分数的組分:  The auxiliary raw material is a component having the following weight percentage:
麩皮 10-12*, 细糠 5-6 地瓜粉 5-6%, 面包酵母 1-1. 2%, 红糖 1-1. 2¾, 碳酸 钙 1-1. 2*;  Bran 10-12 *, fine bran 5-6 sweet potato flour 5-6%, baker's yeast 1-1.2%, brown sugar 1-1. 2¾, calcium carbonate 1-1. 2 *;
所述的菌草酸酶为 0. 02*的所述纤维素酶和 0. 01*的所述真菌蛋白酶; 所述的用于接种的担子菌原浆和 / 或海藻浆的混合物依次为: 香菇原浆, 蘑 菇原浆, 紫菜原浆0 ' ' The bacterial oxalase is 0.02 * of the cellulase and 0.011 * of the fungal protease; the mixture of the basidiomycete puree and / or seaweed pulp for inoculation is: Puree, mushroom puree, laver puree 0 ''
1 7、 如杈利要求 9 或 1 0 所述的制备方法, 其特征在于:  17. The preparation method according to claim 9 or 10, characterized in that:
所述的担子菌与^藻类具 ^如下的重量百'分数:  The basidiomycetes and algae have the following weight percentages:
香菇 15-20%, 海带 -10%;  15-20% shiitake mushrooms, -10% kelp;
所述的中草药具有如下重量百分数的组分:  The Chinese herbal medicine has the following weight percentage components:
何首乌 18-22¾, 女贞子 9-10 怀山药 9·10 桑椹 4-5*和杭白菊 3-4%; 所述的辅助原科为具有如下重量百分数的组分: Polygonum 18-22¾, Ligustrum 9-10 Chinese yam Mulberry 9.10 4--5% 3-4 * and Chrysanthemum; The auxiliary original family is a component having the following weight percentage:
麩皮 10-12¾, 细糠 5-6 酵母 1-1. 2 红糖 1. 5-2. 5 碳酸钙  Bran 10-12¾, fine bran 5-6 yeast 1-1. 2 brown sugar 1. 5-2. 5 calcium carbonate
所述的菌草酸酶为 0. 02*的所述纤维素酶和 0. 的所述淀粉酶;  The bacterial oxalase is 0.02 * of the cellulase and 0.1 of the amylase;
" 所述的用于接种的担子菌原 和 / 或海^浆的混合物依次为: 炅芝原浆, 佥 针菇原浆, 海带原浆。  "The mixture of basidiomycota and / or sea syrup used for inoculation is:
PCT/CN1994/000070 1994-01-08 1994-09-02 A tonic drug made from basidiomycetes, algae, chinese herbal medicine and the method thereof WO1995018626A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU75300/94A AU7530094A (en) 1994-01-08 1994-09-02 A tonic drug made from basidiomycetes, algae, chinese herbal medicine and the method thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN94100345.0 1994-01-08
CN94100345A CN1063331C (en) 1994-01-08 1994-01-08 Method for preparing multifunction health medicine by using fungus, marine alga and Chinese herbal medicine as main raw materials

Publications (1)

Publication Number Publication Date
WO1995018626A1 true WO1995018626A1 (en) 1995-07-13

Family

ID=5029584

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN1994/000070 WO1995018626A1 (en) 1994-01-08 1994-09-02 A tonic drug made from basidiomycetes, algae, chinese herbal medicine and the method thereof

Country Status (3)

Country Link
CN (1) CN1063331C (en)
AU (1) AU7530094A (en)
WO (1) WO1995018626A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100820291B1 (en) 2006-11-10 2008-04-07 제주대학교 산학협력단 Blood coagulation inhibiting composition comprising supernatant from fermentated lomentaria catenata as active ingredient and a method for preparing thereof
CN102321598A (en) * 2011-09-05 2012-01-18 浙江大学 The method of the broken laver cell of one primary yeast displaying type polygalacturonase synergistic supersonic wave
CN105567665A (en) * 2016-03-25 2016-05-11 深圳市先康达生物科技有限公司 Production method of high-efficiency keratinase
CN112753916A (en) * 2020-12-31 2021-05-07 厦门市天德善品生物科技有限公司 Glossy privet fruit beverage for improving eyesight and preparation method thereof
CN112772914A (en) * 2020-12-31 2021-05-11 厦门市天德善品生物科技有限公司 Cordyceps sinensis ginseng mushroom grass nutrient and preparation method thereof

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101361571B (en) * 2008-10-10 2012-09-26 李绩 Edible fungus tonification decoction capable of invigorating kidney and supporting Yang and production method thereof
CN102488253B (en) * 2011-12-28 2013-01-30 青岛明月海洋科技有限公司 Preparation method of active seaweed extract
CN103689353B (en) * 2013-12-06 2016-03-23 安徽汇阳食品有限公司 A kind of blood yiqi health-care powder and preparation method thereof
CN104322917A (en) * 2014-09-26 2015-02-04 安徽省巴克夏种猪育种有限责任公司 Pig feed containing fermented edible mushroom residues and preparation method thereof
CN111281964A (en) * 2019-12-04 2020-06-16 红华御康生物科技(江苏)股份有限公司 Traditional Chinese medicine fermented active polypeptide oral liquid and application thereof
CN112890186A (en) * 2021-02-03 2021-06-04 杭州世子合德生物科技有限公司 Method for extracting enzyme health-care product

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1059662A (en) * 1990-09-10 1992-03-25 黄山秀 The preparation method of health nutrient
CN1062089A (en) * 1990-11-30 1992-06-24 张文明 A kind of technology of prepering natural beverage using adible fungi
CN1064888A (en) * 1992-04-27 1992-09-30 萧河龙 Edible mushrooms and herbal medicine mixed fermentation brewing technology
CN1066788A (en) * 1992-07-01 1992-12-09 王勇 The method for making of body-strengthening nutrient oral liquid and purposes in the Asia
CN1077638A (en) * 1992-04-14 1993-10-27 郝超焰 Preparation method of oral nutritional medicine for pregnant women
CN1081370A (en) * 1992-07-22 1994-02-02 李高霖 Production method of a kind of liquid that keeps healthy and products thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1054514C (en) * 1992-05-11 2000-07-19 卜荣安 Production process of compound gynostemma pentaphylla tea
CN1073872A (en) * 1992-11-02 1993-07-07 武汉三和医药研究所 Oral liquor of snake essence and preparation technology thereof
CN1074130A (en) * 1993-01-04 1993-07-14 陈升坚 Method for preparing Chinese medicinal paste

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1059662A (en) * 1990-09-10 1992-03-25 黄山秀 The preparation method of health nutrient
CN1062089A (en) * 1990-11-30 1992-06-24 张文明 A kind of technology of prepering natural beverage using adible fungi
CN1077638A (en) * 1992-04-14 1993-10-27 郝超焰 Preparation method of oral nutritional medicine for pregnant women
CN1064888A (en) * 1992-04-27 1992-09-30 萧河龙 Edible mushrooms and herbal medicine mixed fermentation brewing technology
CN1066788A (en) * 1992-07-01 1992-12-09 王勇 The method for making of body-strengthening nutrient oral liquid and purposes in the Asia
CN1081370A (en) * 1992-07-22 1994-02-02 李高霖 Production method of a kind of liquid that keeps healthy and products thereof

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100820291B1 (en) 2006-11-10 2008-04-07 제주대학교 산학협력단 Blood coagulation inhibiting composition comprising supernatant from fermentated lomentaria catenata as active ingredient and a method for preparing thereof
CN102321598A (en) * 2011-09-05 2012-01-18 浙江大学 The method of the broken laver cell of one primary yeast displaying type polygalacturonase synergistic supersonic wave
CN105567665A (en) * 2016-03-25 2016-05-11 深圳市先康达生物科技有限公司 Production method of high-efficiency keratinase
CN112753916A (en) * 2020-12-31 2021-05-07 厦门市天德善品生物科技有限公司 Glossy privet fruit beverage for improving eyesight and preparation method thereof
CN112772914A (en) * 2020-12-31 2021-05-11 厦门市天德善品生物科技有限公司 Cordyceps sinensis ginseng mushroom grass nutrient and preparation method thereof

Also Published As

Publication number Publication date
CN1104902A (en) 1995-07-12
CN1063331C (en) 2001-03-21
AU7530094A (en) 1995-08-01

Similar Documents

Publication Publication Date Title
KR100922311B1 (en) Methods of culturing Inonotus obliquus, Phellinus linteus, Ganoderma lucidum, Sparassis crispa and Vegetable Worms for production of substances containing AHCC
CN105641000A (en) Antitumor composition containing grifola frondosus extract and preparation method thereof
CN105559089A (en) Liver-protecting and toxin-expelling fruit and vegetable enzyme and preparation method thereof
CN103740566B (en) Rosa roxbunghii medicinal liquor and preparation method thereof
CN102357212B (en) Compound product obtained through supercritical CO2 extraction, and preparation method thereof
WO2016045310A1 (en) Litholytic enzyme
KR20130077802A (en) The preparing method of immune improving agents
CN107177656A (en) A kind of loach fish protein polypeptide and its application
WO1995018626A1 (en) A tonic drug made from basidiomycetes, algae, chinese herbal medicine and the method thereof
CN106431571A (en) Ganoderma lucidum karst cultivation method for improving ganoderma lucidum polysaccharides and selenium content
CN106174475B (en) A kind of selenoprotein holoside nutrient composite powder and preparation method thereof
CN104522624B (en) A healthcare powder product of edible fungi and a preparation method thereof
CN101664180A (en) Health-care nutritional complexing agent with effect of and preparation method thereof
KR20100001375A (en) New method for preparing the low molecular fucoidan from the brown algae fermentation
KR102172369B1 (en) Method for producing functional eggs by feeding barley sprouts and functional eggs produced by the above method
CN102960711B (en) Natural nourishment and preparation method thereof
CN112370516A (en) A wall-broken Ganoderma spore powder product with active ingredients and its preparation method
CN106728208A (en) A kind of ginseng and lucid ganoderma polysaccharide triterpene preparation and preparation method thereof
CN107896921B (en) Tremella biotransformation composition of maca and dioscorea opposita and preparation method thereof
JPH07284375A (en) Immune-enhanced food compound mainly of isaria-type &#39;tochu-kaso&#39;
JP2003342188A (en) Anticancer agent
JPS60149528A (en) Extraction of active component from mycelium of fomes japonicus
CN109275914A (en) Black fungus polypeptide function edible composition and its preparation method and application
KR880001879B1 (en) A process for healthy drink
CN106418095A (en) Composite edible-fungus-refined-powder solid beverage

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU BR CN GB JP US

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)